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Endothelial cells take up and degrade both low density lipo-
proteins (28) and low density liproteins which have been 
modified by acetylation (AcLDL) (84). In this study, recep-
tors that may be involved in the uptake of these lipoproteins 
were characterized. 
The cells used were aortic endothelial cells obtained from a 
bovine foetus, with subsequent cloning (A3Cl 2 ) . A cell 
culture system which closely resembled the in vivo monolayer 
was established, by growing the cells on gelatin-coated Petri 
dishes. Endothelial cell and lipoprotein interactions were 
examined by incubating the cells with 125 I-labelled lipo-
proteins under various conditions. 
th~ following: 
The main findings were 
The r.eceptor affinity of bovine aortic endothelial cells was 
higher for AcLDL than that for LDL . The half-maximal rates 
of degradation, obtained from degradation saturation curves 
which were linearized using the Scatchard method (136), were 
about 20 µg protein/ml for LDL and about 2 µ9 protein/ml for 
AcLDL. Analyses of binding data were not accurate due to 
the large amount of non-saturable material bound. However, 
the bulk of the lipoproteins was taken up and degraded via 
the saturable process. 
Competition studies demonstrated that there were two distinct 
receptors for LDL and AcLDL on the endothelial cells. AcLDL 
i i i 
did not compete with LDL for the LDL receptor, and conversely 
LDL did not compete with AcLDL for the AcLDL receptor. 
The receptor activities for LDL and AcLDL were examined as 
a function of culture age. Sparse cultures incubated at 
low lipoprotein concentrations (10-20 µg protein/ml} had a 
higher receptor activity for LDL than for AcLDL. ln contrast, 
confluent cultures, catabolized more AcLDL than LDL. In com-
paring sparse to confluent cell cultures, the rate of 125 1-
labelled LDL degradation decreased about twice, while the 
degradation rates of 125 I-labelled AcLDL increased about three 
times. 
Whereas the LDL receptor could be regulated, the AcLDL recep-
tor was not as susceptible to regulation. Up-regulation was 
measured by pre-incubation of the cells with lipoprotein-
deficient serum medium (LPDS-medium) for 48 h. Using degra-
dation data, the LDL receptor was up-regulated about 4-fold, 
whereas the AcLDL receptor was not up-regulated under these 
circumstances. Down-regulation by incubating the cells with 
25-hydroxycholesterol for 24 h resulted in a 96 % decrease in 
the LDL receptor activity and only a 30 % decrease in the 
AcLDL receptor activity. Furthermore, both LDL and AcLDL 
could down-regulate the LDL receptor, but neithe r could down-
re~ulate the AcLDL receptor. 
Upon exposing endothelial cells for 72 h to either LDL or 
AcLDL, it was found that the total amount of cellular choles-
terol increased (by about 50 %). However, the increase of 
iv 
total cholesterol was largely in the form of free choles-
terol. This is in contrast to macrophages, where the in-
crease in total cholesterol upon exposure to AcLDL is 
largely in the form of cholesteryl esters. 
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1. INTRODUCTION 
Atherosclerosis, an important factor in most cardiovascular 
abnormalities, can be accelerated by various factors which 
influence the elevation of blood cholesterol, such as 
genetic disorders (1,2), high cholesterol diet (3,4), hyper-
J.' <2~e. J.o- tension ( 5) and smoking ( 5) ( for a review see reference 6). 
~\elJo,: b\a,c.,J C o 
Most of the circulating cholesterol is synthesized in the 
liver and is secreted as very low density lipoproteins {VLDL) 
which are converted to low density lipoproteins (LDL) upon 
the loss of mainly triglycerides (7). Low density lipo-
proteins carry about 70% of the blood cholesterol which is 
delivered to extrahepatic cells mainly for membrane synthesis 
{for reviews see references 8,9). A massive accumulation 
of cholesteryl ester deposits in the vascular lumen leads to 
the formation of atheros~lerotic plaques. Various cells 
are involved in the complex mechanism of plaque formation, 
among which smooth muscle cells, macrophages and endothelial 
cells play a prominent role. It has recently been shown 
that these cells in culture are able to accumulate choles-
teryl esters upon exposure to modified LDL (for a review see 
reference 10). The endothelium, consisting of endothelial 
cells, lines the lumen of the vascular system, forming an 
\:, "' - l 
interface between the cir~ ulatory system and the underlying 
vascular tissue. Injury of the endothelium and functional 
abnormalities are thus prominent in the pathology of athero-
sclerosis (11, 12). In this introductory chapter, the 
morphology and functions of the endotheiium will be discussed, 
2 
with particular reference to its response to injury {for 
reviews see references 12, 13,14, 15) and metabolism of low 
density lipoproteins (for reviews see references 7,8,9, 16, 
l 7). 
l. 1. MORPHOLOGY OF THE VASCULAR ENDOTHELIUM 
Vascular endothelial cells grow in an ordered monolayer of 
highly flattened, polygonal cells resembling a cobblestone 
pavement. Their long axis, which ii about 20-50µ in length 
is orientated in the direction of blood flow. The width of 
these cells is about 10-15µ (for review see reference 12). 
The endothelial cells have large nuclei and the cytoplasm 
contains many mitochondria, rough and smooth endoplasmic 
reticulum, well-developed Golgi apparatus, lysosomes and 
microtubules (Plate 1. 1). All arterial endothelial cells, 
with the exception of bovine aortic endothelial cells, are 
further characterized by the presence of Wiebel-Palade 
bodies (18, 19,20,21). These are rod-shaped organelles with 
as yet undetermined functions. 
The endothelium exhibits both a morphological and functional 
polarity. The side exposed to the bloodstream is non-
thrombogenic, whereas the abluminal surface is thrombogenic 
(21,22). This is of great importance, as platelet adhesion 
to the endothelium is normally prevented, as well as the pos-
sibility of thrombus formation which could initiate the 
atherosclerotic plaque (13). In addition, the luminal 
PLATE 1.1: ELECTRON MICROSCOPY OF ENDOTHELIAL CELLS IN 
CULTURE 
Transmission electron micrograph of cell strain A3c1 2 in 
culture (transverse section) . 
A portion of an endothelial cell (A 3c1 2 ) in culture. The 
cell can be seen to have a large nucleus (N). The cytoplasm 
consists of numerous mitochondria (M) and plasmalemmal 
vesicles (PV) as well as lysosomes (L). The basement mem-
brane (BM) is found on the abluminal surface . 
., 
Magnification= 25000 x 
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surface synthesizes and secretes various metabolites such 
as prostacyclin (PGI 2), adenosine, plasminogen activator 
and the angiotensin-converting enzyme which aid in the 
maintenance of a thrombo-resistant surface (20,23,24). 
Furthermore, the luminal surface of the endothelium is 
characterized by the presence of the antihaemophilic factor 
antigen (19,25,26) . This is thus a useful means for iden-
tifying endothelial cells. The basement membrane is syn-
thesized by the thrombogenic surface. Although the exact 
nature and composition of the basement membrane is still to 
be elucidated, it is composed of multiple layers of different 
collagenous material, as well as glycosaminoglycans, proteo-
glycans and glycoproteins (21,22,27). Studies in vitro 
have shown that fibronectin, which coats_ the me m~rane, is 
responsible for cell adhesion (21,28), and another major 
cell surface protein with a molecular weight of 60 000 
(CSP-60) is responsible for the confluent, ·contact-inhibited 
mono1ayer (21,28,29). 
Furthermore, the endothelium contains numerous plasmalemmal 
vesicles (30) ana a va ri ety of intercellul~ r Junct i on s (31J. 
0 
The plasmalemmal vesicle~have a mean diameter of 600 A. · 
Ultrastructural studies have shown that some plasmalemmal 
vesicles are situated entirely within the endothelial cyto-
plasm, while others open into the luminal or subendothelial 
space, by fusion with the plasma membrane {30). Not only 
are the plasmalemmal vesicles far more abundant on the 
abluminal surface, but their relative number also varies 
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between different segments of the vascular system (12). 
F o r e x a mp l e , s i m i o n e s c u ·~ ·.!I_ ( 3 2 ) ob s e r v e d th at th e a rte r i o l a r 
endothelium had a much smaller population of plasmalemmal 
vesicles than did the capillaries. lnterendothelial junc-
tions with a mean diameter of 30-40 ~' are also found to 
differ morphologically and functionally, depending on the 
type of endothel .ium (12). The endothelium can be divided 
into two main categories: the continuous endothelium, which 
is found in the arteries, veins and capillaries; and the 
fenestrated endothelium of various forms of visceral capil-
laries (33,34). Simionescu ~ ~ (32,35) observed that 
arterioles have the most elaborate junctional system. This 
system is composed of tight junctions surrounding large gap 
junctions. The arteries have a similar network with con-
siderably less complex tight and communicating junctions {35). 
Capillaries, by contrast, have no communicating junctions and 
are less organized. Venules have the least organized junc-
tions, which are mostly devoid of junctional particles. The 
complexity of the junctional arrangement in the endothelium 
is further emphasized by the work of Schwartz and Benditt (36). 
In the aortic intima of rats alone, they identified four types 
of inter-endothelial junctions. The most common junction was 
a mortice junction, followed by the complexly-folded junction, 
the simple-overlap junction, with the least common being the 
single end-to-end junction. It has been shown in vitro that 
both the plasmalemmal vesicles and the intercellular junctions 
of endothelial cells are involved in a transport mechanism 
(see Introduction 1.5). 
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1.2. GROWTH AND PROLIFERATION OF VASCULAR ENDOTHELIAL CELLS 
IN VITRO 
The ease with which vascular endothelial cells are obtained 
and grown in vitro, is largely due to the pioneering work 
carried out by Lewis since the 1920s (37). Vascular endo-
thelial cells are isolated either by mechanical scraping 
(38,39) or by enzymatic release (19,20,40,41,42). The growth 
of endothelial cells in culture varies according to the sub-
strates used. When bovine aortic endothelial cells are 
exposed to plastic, their orientation is such that the basal 
layer adheres. Once these cells form a confluent monolayer 
with newly synthesized basal materials, such as collagen, 
proteoglycans and glycoproteins, a second layer is formed 
beneath. The latter attaches in an inverted manner to the 
original culture, with the apex of the cells in contact with 
the plastic (43). When this second layer is restricted to 
focal areas, where the cells do not proliferate beyond a 
small number, then this phenomenon has been referred to as 
11 sprouting 11 (19), in contrast to cells which take over the 
whole culture and form multi iaye rs . McAus l an ~ ~ (44), 
who observed a similar morphology, prefer to refer to the 
"sprouting" cells as variant endothelial cells, which are 
found to grow both over and under the monolayer of endo-
thelial cells. Since correlations have been drawn between 
endothelial cell behaviour and function, and biosynthetic 
or artificial extracellular substratum, the growth of endo-
thelial cells on extracellular matrix derived from corneal 
endothelial cells (21,22,45), collagen (42,46,47) and gelatin 
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(48) have been studied. The extracellular matrix from 
corneal endothelial cells was able to sustain the growth 
rate of corneal and vascular endothelial cells (45). 
Bovine aortic endothelial cells and capillary endothelial 
cells were grown on collagen gels in order to study tumour 
invasion of the in vitro endothelial monolayer (47,49). 
Human umbilical endothelial cells grown on fibrillar type I 
collagen were used as a model to study platelet adhesion 
( 42). Gelatin was used as a parameter together with tumour-
conditioned medium for maintenance of capillary endothelial 
cells for a long period of time in culture (48). A substratum 
for endothelial cell growth.!!!_ vitro is not essential, but it 
may allow for enhanced growth, as a substitute for growth 
factors (27). 
As mentioned, the proliferation of vascular endothelial cells 
which has been extensively studied (for reviews see 21,22,50), 
is found to be rather varied. Population doubling times in 
bovine endothelial cells vary in different media and sera (41) 
having a range from 29 h (51) to 3-4 days (19) . This wide 
range is also dependent on the proliferative agents used to 
maintain growth of these cultures. 
A potent mitogen for endothelial cells is fibroblast growth 
factor (22,38,52,53). Gospodarowicz and coworkers (38) 
isolated and maintained bovine endothelial cells in the 
presence of fibroblast growth factor (FGF, 100 ng/ml). In 
the absence of FGF, cells proliferated at a very much slower 
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rate and lost the ability to form a confluent contact-
inhibited monolayer as found i!!_ vivo (22,54). However, if 
cells were grown in the presence of FGF for some time (12 
days), and thereafter FGF was removed, the confluent, contact-
inhibited monlayer was maintained for at least 7 days {38). 
Controversies regarding FGF have arisen, with ·Duthu et al 
(41) reporting that cells grown in the presence of FGF do in 
fact multilayer. Schwartz~~ (50) also contradict 
Gospodarowicz ~ ~ (22) in that these workers were unable 
to show an increased mitogenic effect of FGF. 
Platelets have been shown to produce growth factors which 
enhance the proliferation of smooth muscle cells (22,21). 
The effect of these factors on endothelial cells was looked 
at by Gotlieb and Wong (55) and Davies and Ross {56). 
Although incubation of endothelial cells in plasma-derived 
serum (PDS) slowed down cell spreading if compared to incu-
bation of endothelial cells in whole blood serum (WBS) (55), 
the cell growth rate did not differ between cells exposed to 
20 % PDS, 20 % WBS or 20 % PDS containing the platelet-derived 
growth factor (56). It was assumed therefore that the presence 
of platelets and their growth factors did not enhance endo-
thelial cell proliferation. In a report by Gospodarowicz 
and Charles (57), bovine aortic endothelial cells plated on 
plastic had a slower growth rate when exposed to plasma than 
to serum. In contrast, when the cells were plated on an 
extracellular matrix, they proliferated equally well, whether 
they were exposed to plasma or serum. When the effect of 
8 
whole blood serum (WBS) alone was looked at, it was shown 
that endothelial cell growth relied on the correct concentra-
tion for optimal growth. This was found to be a concentra-
tion of 20% serum (50). At the low concentration of 1% 
serum endothelial cells grew very slowly, even upon the 
addition of mitogens such as FGF, EGF (epidermal growth 
factor) and insulin (50). 
Recently, Gospodarowicz ~ ~ {27) have shown that if endo-
thelial cells are grown on an extracellular matrix {ECM) in 
the presence of plasma, FGF is no longer required to attain 
a confluent monolayer. Endothelial cells grown on an ECM 
no longer proliferate if they are exposed to lipoprotein-
deficient serum (LPDS). It thus appears that the presence 
of lipoproteins is necessary for endothelial cell prolifera-
~ e 
tion. In adding either low density lipoproteins {LDL) or 
~ 
high density lipoproteins {HDL) to the LPDS-medium, it was 
found that although low concentrations of LDL (150 µ9 
protein/ml) expressed full mitogenic capabilities, higher 
concentrations became toxic for the cells (58). The toxic-
ity of high concentrations of LDL was a function of cell 
density. When the cells were confluent, LDL even at a 
physiological level (600-800 µg protein/ml) was no longer 
toxic (59). HDL, on the other hand, proved to be mitogenic 
over a wide range of concentrations, even at the physiologic 
concentration of 1000-1500 µg protein/ml (59), and was 
thought to be the preferred lipoprotein for enhanced proli-
feration. In addition, endothelial cells maintained on 
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ECM could be grown in completely serum-free medium if supple-
mented with HDL and transferrin (58). The requirement of 
transferrin could reflect either its role as an iron-carrying 
protein capable of delivering this metal to the cells or as a 
detoxifying protein removing trace amounts of toxic metals 
that would otherwise have been removed by serum proteins (60). 
Furthermore, Tauber and Gospodarowicz (61) investigated the 
effect of LDL and HDL on cell migration and proliferation on 
the repair process of a wounded confluent monolayer. Whereas 
HDL added to LPDS-medium leads to a rapid repair process, LDL 
at high concentrations adversely affects the repair process. 
Further studies will be indispensable in elucidating the role 
of lipoproteins in wound repair. 
Wound-derived macrophages and wound fluids have also been 
shown to stimulate vascular endothelial proliferation (62). 
A 2% wound fluid concentration causes proliferation of endo-
thelial cells comparable to 100 ng/ml FGF (62). The sub-
stance in wound fluids responsible for the mitogenic behaviour 
is not yet known. However, it has been shown that macro-
phages produce a growth fac to r (MDGF) independently of plasma-
or platelet-serum growth factors (63,64,65), and it is pos~ 
sible that this factor, which has also been shown to be mito- · 
genie for endothelial cells (63,52) may be released by the 
macrophages into the wound fluid. 
Although there are many different and often conflicting 
reports on the growth and proliferation of vascular endo-
thelial cells, it has been possible to maintain them in 
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culture. As far as growth i..!!_ vitro is related to LDL 
metabolism, it has been reported that when cells are grown 
to a confluent, contact-inhibited monolayer (21,28,66), the 
LDL particle is bound, but no longer internalized or degraded. 
This has been found to be the case only with endothelial 
cells grown according to the method of Gospodarowicz (22,38, 
54). However, Coetzee and coworkers (67) did not find that 
the amount internalized and degraded by bovine endothelial 
cells in confluent cultures was negligible, although they 
did observe a decrease in LDL metabolism with increasing cell 
confluence. 
1.3. THROMBOGENESIS 
When the endothelial layer of cells is removed to expose the 
underlying surface, platelets can adhere and thrombus forma-
tion occurs. This can be further aggravated if macrophages 
and platelets release growth factors which cause smooth 
muscle cells to proliferate into the intima and eventually 
lead to atherosclerotic plaque formation (13). As a preven-
tative measure, the endothelium actively metabolizes and 
secretes various vasoactive substances, which participate in 
maintaining a non-thrombogenic luminal surface. The endo-
thelium and blood platelets produce metabolites from arachi-
donic acid which are involved in thrombogenesis. 
In both endothelial cells and platelets, arachidonic acid is 
converted to prostaglandin endoperoxides (PGE 2 and PGH 2) by 
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the action of cyclo-oxygenase (68~69). In the case of the 
endothelial cells, the prostaglandin endoperoxides are con-
verted to prostacyclin (PGI 2) by prostaglandin synthase, 
while in platelets they are converted to thromboxane A2 
(TxA 2) by thromboxane synthetase. PGI 2 is a vasodilator 
and inhibitor of platelet aggregation. TxA 2 , on the other 
hand, is a vasoconstrictor and inducer of platelet aggrega-
tion. The protection by endothelial cells against thrombo-
genesis is also seen in the ability by these cells to catab-
olize exogenous adenosine triphosphate (ATP) to adenosine 
(24), which is an inhibitor of platelet aggregation (70). 
Promotors of platelet aggregation such as serotinin (23), 
b'fci..~ 
adenine nucleotides (24,70), bardykin}n (20) and angiotensin 
I (20) are removed by endothelial cells. For example, 
angiotensin I is converted to angiotensin II, which indirectly 
stimulates the release of PGI 2 (20). 
When thromboxane A2 formation is increased, or prostacyclin 
formation inhibited, increased platelet adhesion to the endo-
thelium occurs (71). Thrombin, an activated coagulation 
factor, which is known to bind to cultured human and bovine 
endothelial cells (72,73) is a strong inducer of platelet 
aggregation. There is a large production of malondialde-
hyde (MDA) by platelets~ vitro in response to thrombin 
( 7 4 ) • Aspirin, which inhibits platelet aggregation (75), 
also inhibits production of malondialdehyde by platelets 
( 7 4 ) • Hammerstrom et al (68) have shown that malondial-
dehyde is a by-product of prostaglandin endoperoxide con-
version to thromboxane A2 in platelets. 
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The production of platelet substances~ vitro have been 
shown to modify LDL, and cause cholesteryl .ester accumula-
tion in macrophages (76). Macrophages had been shown to 
have receptors for negatively-charged LDL which can be in-
volved in cholesteryl ester accumulation under certain con-
ditions (77). Brown et al (78) used acetylated-LDL (AcLDL) 
as a source of negativ~ly-charged LDL, while Fogelman used 
malondialdehyde-treated LDL (MDA-LDL) (76,77,79). Both 
these modified lipoproteins bound to the same receptor on 
macrophages (78). When the LDL, which had been modified 
upon exposure to platelet substances, was compared to MDA-
LDL, it was found to have the same elution profile on Sepha-
rose 48. Upon hydrolysis of the LDL particle, which had 
been exposed to platelet substances, it was spectrophoto-
metrically determined to consist of malondialdehyde (76). 
Not only was malondialdehyde the first molecule to be found 
..:!.!:!_ vivo at the appropriate site where the initiation of 
atherosclerosis could occur, but it was also produced in 
large enough quantities to modify LDL in such a way that 
the lipoprotein was able to cause subsequent cholesteryl 
ester accumulation (76) (See Introduction 1.5). 
1.4 ENDOTHELIAL RESPONSE TO INJURY 
As early as 1856, Virchow (80) suggested that injury to the 
artery wall somehow led to a series of tissue responses, 
that culminated in the lipid-filled lesions of atherosclerosis. 
In recent years, the studies of injury to the artery wall 
1 3 
have focussed on the endothelium {for reviews see references 
13, 14). When the intact endothelium is injured in experi-
mental procedures by means such as exposure to mechanical 
forces, various toxins, . immunological injury, viruses and 
chemical agents such as low density lipoproteins {13,14,81), 
the endothelial monolayer is disrupted, exposi ·ng the under-
lying connective tissue. The presence of basement membrane 
collagens, type IV and V (42) and the interstitial collagens, 
type I and III (82), greatly enhance platelet adhesion. 
Disruption of the endothelial monolayer may lead to changes 
such as separations between · endothelial cells, altered endo-
thelial permeability or desquamation of the endothelial cells, 
in which both adherence of platelets and of monocyte-macro-
phages may occur. Substances derived from platelets and 
monocyte-macrophages, as well as from the plasma, such as 
lipoproteins andhormones may stimulate the migration of 
smooth muscle cells from the media into the intima, where 
proliferation of these cells may be induced (13) {Figure 1.1). 
Habernicht ~ 2-.l {83) reported that the platelet-derived 
growth factor {PDGF), in addition to enhancing quiescent 
smooth muscle cell division, also increased cholesterol bio-
synthesis in cultured smooth muscle cells. Furthermore, 
as mentioned earlier, the release of malondialdehyde into 
the bloodstream by platelets upon aggregation can cause 
modification of the LDL particle. At the site of injury 
of the endothelial monolayer, where platelet aggregation 
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FIGURE 1. 1. ARTERIAL WALL: CONSEQUENCES OF ENDOTHELIAL INJURY 
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reaching implications, since this modified LDL (MDA-LDL) has 
'(e c, '-'' ... i 
been shown to be taken up by monocyte-macrophages _!' ith the 
result of a] cholesteryl ester accumulation {76). It has 
been reported that the ability of macrophages to metabolize 
negatively-modified LDL {MDA-LDL or AcLDL) l.!!. vitro is 
shared by endothelial cells (84), but not by smooth muscle 
cells or fibroblasts (10). However, when smooth muscle 
cells are exposed to the medium of either macrophages or 
endothelial cells incubated with negatively-modified LDL, 
in the form of AcLDL, these cells accumulate cholesteryl 
esters (85,86). Although it is rather appealing to link 
various in vitro studies to explain the in vivo situation of 
lipid-filled macrophages and smooth muscle cells at the site 
of atherosclerosis, it should be pointed out that the in vitro 
systems used are rather specialized and have yet to be con-
firmed in vivo. 
It is further postulated that if injury to the endothelial 
monolayer is limited, the process of plaque formation is 
reversible and regression of the lesion is obtained. 
Regression of the lesion occurs by the two separate mechan-
isms of migration followed by replication {15). Upon 
wounding a confluent endothelial cell layer in culture, the 
cells at the wound edge first appear to spread themselves 
over a larger area to close the wound, while remaining 
attached to the adjacent cells (13, 15). It is thought 
that only if the wound is too large do the cells respond by 
replication. The migration of endothelial cells is possible 
due to the presence of actin fibres. Cell movement usually 
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begins with the protrusion of a broad flattened portion of 
the cytoplasm (the lamellipodium) away from the main cell 
body in the directionof cell movement (87). After attach-
ment, translocation occurs by retraction of the actin fibres 
associated with the cell membrane. Cytochalasin B has been 
shown to inhibit cell motility by disrupting the submembrane-
ous webof actin fibres (21,88). Apart from preventing mig-
ration, cytochalasin B also prevents replication at wound 
edges (89), strongly suggesting the possibility that replica-
tion is dependent on the movement away from the intact sheet. 
1.5. TRANSPORT ACROSS THE AORTIC ENDOTHELIUM 
In the 1950 1 s, the classical pore theory was developed to 
clarify the mode of transport through the continuous layer 
of endothelial cells which line the vascular lumen of blood 
vessels. This theory postulated the presence of two-pore 
systems: A large-pore of 250-700 ~ and a small-pore of 50-
90 i in diameter {91). Since the exact location of these 
pores on the endothelium had been disputed for many years, 
various tracer molecules of known size have been used to 
resolve this uncertainty. This section concentrates mainly 
on investigations in search of lipoprotein transport using 
tracer molecules. {For a more general review of endothelial 
transport see reference 12). 
Stein and Stein (31) used the tracers horseradish peroxidase 
(MW 40 000) and bovine milk lactoperoxidase (MW 82 000) to 
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follow the macromolecular transport through the endothelium 
of mouse aorta. They observed that horseradish peroxidase 
transport was concentration-dependent. When 0.25 - 0.5 mg 
of horseradish peroxidase was injected, transport was via 
the plasmalemmal vesicles, while injection of 5 mg of enzyme 
resulted in transport via both plasmalemmal vesicles and 
intercellular junctions (31}. On the other hand, lacto-
peroxidase was transported only via the plasmalemmal 
vesicles. These early investigations suggested that the 
intercellular junctions were the location for the small-pore 
system. This was further investigated with markers of 
smaller molecular size, such as myoglobin (MW~ 17 800) and 
heme peptides (MW~ 1 900). Neither of these tracers was 
observed on the intercellular clefts, although they had 
already appeared in the subendothelial space (92). It was 
thus suggested that any sign of marker in the intercellular 
junctions was probably due to diffusion with time, and that 
these were not the location of the small-pore system. The 
discovery of transendothelial channels which are formed by 
transient fusion of plasmalemmal vesicles, led to the accep-
tance of these channels as the small-pore system (92). The 
channels fit the requirement of the pore theory in that they 
are water-filled passages connecting the lumen with the 
tissue spaces, having size limiting structures of about 
0 
100 A. 
Agreement has been reached as to the location of the large-
pore system in the plasmalemmal vesicles by tracers such as 
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ferritin and lactoperoxidase. It is thought that lipo-
proteins use the large-pore system of transport, after 
various studies in different species (90,93). The studies 
carried out can be divided into two main groups: those 
that made use of labelling the cholesteryl ester moiety and 
those that labelled the protein component of lipoproteins. 
The method of radioautography using protein-labelled lipo-
proteins was employed to study the transport of 125 I-lipo-
proteins, such as human VLDL, LDL, HDL, delipidated HDL 
apolipoprotein and rat HDL in a perfusion of rat aorta and 
heart (93). The outcome of this investigation was that 
plasmalemmal vesicles participated in the transport and 
that the whole lipoprotein particle was taken up. Apart 
from this non-receptor mediated transport of lipoproteins, 
it is known that endothelial cells possess saturable high 
affinity receptors for LDL, which allow for a regulated 
uptake of LDL (see Introduction l .7). 
1.6. THE ORIGIN AND COMPOSITION OF LDL 
The cholesteryl esters found in atherosclerotic plaques 
have been suggested to be mostly derived from the cholesterol 
which is delivered to the cells by the LDL particle (10,94). 
There are two lipid sources for the circulating plasma lipo-
proteins: exogenous dietary fat and endogenous synthesis 
by the liver (7). Chylomicrons, rich in triglycerides, 
are secreted from the intestinal mucosa following the absorp-
tion of digested fats. The other triglyceride-rich lipo-
1 9 
protein, VLDL, is synthesized predominantly in the liver 
from non-lipid precursors such as glucose (7) (Figure 1.2). The 
catabolism of VLDL and chylomicrons is initiated by hydro-
lysis of their triglyceride moiety by lipoprotein lipase. 
The enzyme is bound at the luminal surface of capillary 
endothelium. The released fatty acids are taken up largely 
by the muscle cells and adipocytes. The structural peptide 
of VLDL, apoprotein B, is retained as the lipoprotein par-
ticle, and is catabolized through a range of products, in~ 
eluding smaller VLDL, then intermediate-density lipoprotein 
(IDL) and finally low density lipoprotein {LDL). Not only 
the apo B, but also cholesteryl esters are stable components 
of this series of lipoproteins. Although some studies in-
dicate that most of the apo B of VLDL is normally converted 
to the apo B of LDL, other observations suggest that this 
conversion is only partial (95). In addition, the choles-
teryl ester component of LDL is increased, presumably 
through the action of the plasma enzyme, lecithin: choles-
t er o l a cy 1 transfer as e (LC AT) ( 9 ) . The studies of Glomset 
(96) suggest ~hat HDL is the source of free cholesterol 
that becomes the esterified cholesterol of LDL. 
The low density lipoprotein particles of human plasma have 
a dens i ty range of l . 0 l 9 to l . 0 6 3 g /ml and a mo l e cul a r 
weight of about 2 - 3.5 x 106 daltons with a diam~ter of 
200 - 250 ~ (9). The variation in size and molecular 
weight has been shown to be due to the varying amount of 
lipid in the core of the lipoprotein particle, rather than 
Figure 1.2: Schematic representation of endogenous 
LDL synthesis 
Code: VLDL = very l OW density lipoproteins 
IDL = intermediate density . lipoproteins 
LDL = l OW density lipoproteins 
HDL = high density lipoproteins 
R = receptor site 




































































































































































to the variation in the protein composition (97). Lipids 
comprise 75% of the mass of the LDL particle and the protein 
makes up 25%. The lipid component of LDL consists primarily 
of an apolar core of neutral lipids, mostly esterified 
cholesterol (60%) with phospholipids {30%) and free choles-
terol (10 %) surrounding it. Apolipoprotein B (apo B), the 
polypeptide moiety of LDL, directs the particle to its site 
of catabolism. This protein has remained poorly charac-
terized, primarily due to its marked insolubility in aqueous 
solutions in the absence of amphiphiles or denaturants (104). 
Many of its properties continue to be disputed with widely 
varying estimates of its molecular weight. These conflicting 
results could be attributed to the different methods employed 
to characterize the protein, such as delipidation {98), 
proteolytic activity {99,100), the use of various denaturing 
agents (101,102) and detergents (103,102). In addition, 
there is a high tendency for the subunits of the apoprotein 
B to aggregate (105) and the possibility of reaction between 
protein and auto-oxidizing lipids {106) which further com-
plicate the research. Some data in the literature indicate 
that apo B consists of high molecular weight proteins (107, 
109), while others indicate that apo B consists of subunits 
{98,105). The estimates of the molecular weight of apo B 
have ranged from 8 000 to 450 000 (101,98, 108,106). Socorro 
and Camejo (108) drew some interesting conclusions, that when 
ape B is prepared by side chain modifications and organic 
solvent extraction, intermediate molecular weight subunits 
(26 000 - 80 000) are detectable in the presence of ionic 
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detergents and/or urea; when only organic solvents are 
used, apo Bis associated and has molecular weights ranging 
from 250 000 to 318 000; and when detergents are used in 
the absence of organic solvents, then small subunits of 
molecular weight 8 000 to 10 000 are present. 
In general, there appears to be some agreement that the 
monomeric state of apo B consists of a molecular weight 
of 250 000 to 270 000 (102,107,112). Additionally, it 
has been shown that delipidated LDL can be reconstituted 
with yolk lecithin yielding a 500 000 g/mol complex, which 
is the dimeric form of apo B, forming a quaternary struc-
ture (110). Zampighi ~ ~ (111) complexed the apo B to 
the detergent, n-dodecyloctaethyleneglycolmonoether. This 
· protein-detergent complex was investigated using electron 
microscopy, and a rod-shaped particle composed of 2 copies 
of apo Band 5-6 equivalent micelles of detergent was 
observed. This asymmetrical particle had a high degree of 
flexibility with a strong tendency to self-associate, the 
latter being pH-dependent. Although the width of the 
complex remained fairly constant (4-5 nm), the length was 
variable (~so nm). 
Since apoprotein B directs the LDL particle to its site 
of catabolism, it is of immense value to obtain increasing 
knowledge of the structure of the protein, in order to gain 
a deeper insight of its functional aspect. In a later 
section (Introduction l .8), modification of amino acids of 
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the apoprotein B will be discussed, with special reference 
to the effect of LDL uptake by a variety of cells. 
1.7. THE LOW DENSITY LIPOPROTEIN PATHWAY 
High affinity receptors, specific for LDL, have been shown 
to be situated on the surface of extrahepatic cells such as 
human skin fibroblasts (113,114), endothelial cells (21 ,54, 
66,67), smooth muscle cells (115,116) and adreno-cortical 
cells (117). These glycoprotein cell surface receptors 
are also known as the apo B-E receptors as they can bind 
lipoproteins containing either apoprotein B or apoprotein E 
(166,167) (see Figure 1.3). 
LDL particles bind to the apo B-E receptors, which are 
situated in coated pits on the cell surface. These coated 
pits, which represent 2% of the cell surface, contain about 
70 % of the apo B-E receptors (168). The major constituent 
of the coated pits is a polypeptide, clathrin (118). Sub-
sequent to binding, the LDL particle is internalized via 
endocytotic vesicles, which eventually fuse with the lyso-
somes (169). It has been speculated that receptor-ligand 
dissociation occurs before the endocytotic vesicle has 
reached and fused with the lysosome (165), with the subsequent 
event of receptor recycling. Within the lysosomes, the apo-
protein moiety is degraded by lysosomal proteases to amino-
acids. The cholesteryl esters are hydrolysed to free choles-
terol by a lysosomal acid lipase. The unesterified choles-




































































































































































































plasmic compartment, where it triggers three regulatory 
responses: 
(l) the suppression of the activity of 3-hydroxy-3-methyl-
glutaryl CoA reductase. This is the rate-limiting 
step in cholesterol biosynthesis within the cell; 
(2) the suppression of the synthesis of the LDL receptors; 
and 
(3) the activation of acyl CoA: cholesterol acyl transferase 
(ACAT). This enzyme converts excess cholesterol to 
cholesteryl esters for storage as lipid droplets (119). 
The · continual functioning of these regulatory mechanisms is 
of utmost importance in the regulation of cellular choles-
terol levels. 
1.8. MODIFICATIONS OF LDL RELATED TO CHOLESTERYL ESTER 
ACCUMULATION IN CELLS 
It is difficult to define the mechanism responsible for the 
lipid accumulation characteristic of atherosclerosis, since 
LDL, the major carrier of cholesterol into the arterial wall 
is taken up by cells via a well-regulated pathway (for 
reviews see 8,9). An excess of cholesterol triggers the 
three feedback control mechanisms (described in Introduction 
1.7), preventing abnormal cellular accumulation of choles-
teryl esters in cells under normal conditions. 
When the apoprotein B moiety of LDL is chemically modified, 
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an over-accumulation of esterified cholesterol in various 
cell types 1.!!_ vitro such as human monocyte-derived macro-
phages (76,120), mouse peritoneal macrophages (78), smooth 
muscle cells (83,86), endothelial cells (84) and fibroblasts 
(121), has been observed. When LDL is chemi~ally modified 
to a cationized form, which is more electropositive than 
normal LDL, it is taken up by fibroblasts (121) and smooth 
muscle cells . (122) by a low affinity, non-saturable mechanism. 
An enhanced electropositive charge on LDL was also obtained 
by desialyzation of the LDL particle by neuraminidase treat-
ment (123,124,125). However, although cells incubated with 
cationized LDL resulted in the appearance of numerous choles-
teryl ester droplets, those with desialyzed~LDL did not (10). 
Desialyzed-LDL is · taken up via adsorptive endocytosis, and 
interestingly, if exposed to receptor-deficient cultured 
human skin fibroblasts, was shown to have the ability to 
regulate cholesterol metabolism (125). Although cationized-
LDL caused a cholesteryl ester increase in some cells, the 
problem remained that the LDL isolated and purified from 
plaques had a more electronegative charge relative to plasma 
LDL (126). This led to various modifications of LDL to 
obtain an electronegative particle that would be taken up 
by cells and result in a cholesteryl ester accumulation. 
Recent studies by Goldstein~~ (127) showed that mouse 
peritoneal macrophages bind and internalize LDL by a high 
affinity process if the LDL has been acetylated, thus in-
creasing its net negative charge. The uptake of acetylated-
LDL (AcLDL) is not via the apo B-E receptor. The feedback 
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control found with apo B-E receptors is absent and thus 
cholesteryl ester accumulation in these macrophages occurs. 
Since mouse peritoneal macrophages do not catabolize normal 
LDL (78,127), lipid accumulation in the~e cells is largely 
due to the uptake of modified LDL. Mahley~~ (128) have 
also shown that canine peritoneal macrophages take up and 
degrade acetoacetylated-LDL at a much higher rate than native 
LDL. Furthermore, in vivo studies of the clearance of 
acetoacetylated-LDL from the plasma of rats, resulted in the 
modified lipoprotein being found in the liver, where the 
Kupffer cells were responsible for its rapid removal (129, 
1 3 0 ) • 
Although it has not yet been demonstrated that chemically 
modified LDL, such as cationized LDL or AcLDL are produced 
..:!._!!_ vivo, the production of malondialdehyde upon platelet 
aggregation (50,74,131) can result in a negatively modified 
LDL which causes cholesteryl ester accumulation in monocyte-
macrophages (76). Another source of malondialdehyde is at 
the site of lipid peroxidation (132). Incubation of macro-
phages ..:!._!!_ vitro with malondialdehyde-treated LDL (MDA-LDL) 
has resulted in massive cholesteryl ester accumulation (76, 
77,133). Neither native LDL nor MDA-LDL can regulate the 
MDA-LDL receptor, yet both can downregulate the LDL receptor 
( 1 33 ) • This inability to regulate the receptor for MDA-LDL 
could perhaps account for the large cholesteryl ester accumu-
lation which occurs in these monocyte-macrophages. An 
interesting factor of this MDA-LDL receptor in monocyte-
macrophages is that AcLDL is .also recognized (77). Conversely, 
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the receptor in mouse peritoneal macrophages which bound 
AcLDL, also recognizes MDA-LDL, and thus it appears that 
there is one receptor which recognizes and binds both 
forms of negatively-modified LDL (77,78). This receptor 
found in macrophages is not expressed in fibroblasts, smooth 
muscle cells, lymphocytes or adrenal cells (78), but it is 
fou nd in endothelial cells (84). Although this receptor 
is not found in smooth muscle cells, when these cells are 
incubated with medium containing AcLDL pre-incubated with 
either macrophages or endothelial cells, they become lipid-
laden (85,86). 
During the same period, Henricksen~~ (94) showed that 
if medium containing LDL was exposed to endothelial cells, 
the LDL particle is modified in such a way that when post-
incubated with macrophages, it is taken up vii the same 
receptor as for AcLDL. This effect was specific for endo-
thelial cells, and as yet has not been used to look at 
possible cholesteryl ester loading. The ability of endo-
thelial cells.:!...!: vitro to modify LDL and allow for its up-
take by a receptor-mediated pathway in macrophages is a 
rather interesting observation, especially if it was to be 
found to cause lipid loading in macrophages as well. 
Together with the various other ways in which LDL is modified, 




Numerous in vitro studies on endothelial cells have revealed 
their various mechanisms for maintaining an intact monolayer 
of contact-inhibited cells. Among these are their ability 
to produce or respond to metabolites to overcome endothelial 
damage and to prevent thrombogenesis. An interesting 
feature of endothelial cells is that they possess a receptor 
for negatively-modified LDL which has also been found in 
macrophages, but not in fibroblasts, smooth muscle cells, 
lymphocytes or adrenal cells (78). In macrophages, the 
receptor for negatively-modified LDL has been studied with 
respect to its activity, regulation and cholesteryl ester 
accumulation, but as yet this receptor in endothelial cells 
has not been thoroughly investigated. An attempt has been 
made to answer the following questions regarding the inter-
action of endothelial cells and low density lipoproteins: 
How do the receptor affinities for LDL and AcLDL differ? 
What effect does the cell density of endothelial cells have 
on the receptor activities? Are there two separate, distinct 
receptors? If so, how do they differ? How and to what 
extent are these receptors regulated? Are they able to 
regulate the cholesterol content within the cells, or do 
they allow intracellular cholesteryl ester accumulation? 
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OUTLINE OF PROPOSED RESEARCH 
The aim of the present study was to investigate the uptake 
and catabolism by endothelial cells of LDL which had been 
acetylated (AcLDL). In the acetylation reaction, acetyl 
groups are attached to the lysine residues of LDL; this 
neutralizes the posjtive charges and increases the net 
negative charge of the protein. A comparative study of 
the handling of LDL and AcLDL by endothelial cells was 
envisaged. 
The experimental model system chosen was cultured bovine 
aortic endothelial cells. These cells were obtained by 
mechanically scraping the lumen of the aorta of a 2-3 month 
old bovine foetus. Although cultured cells need not 
reflect the~ vivo situation, there are far more possibili-




To establish the receptor behaviour in endothelial cells 
suitable conditions for assaying lipoprot e in binding and 
catabolism were investigated. These conditions would 
allow for the characterization of receptor and non-receptor 
pathways and the distinction between LDL and AcLDL receptors. 
Since there had been a controversy about the LDL receptor 
activity with cell density (21,66,67,163), it was useful to 
establish the behaviour of the LDL receptor in these cells. 
The possible regulation of receptor activity in cultured 
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cells by factors such as cell density and cholesterol were 
therefore examined. 
The effect of inhibitors of lysosomal function was measured 
to establish whether AcLDL was delivered to the lysosomes 
for degradation. Furthermore, the release of cholesterol 
from AcLDL was investigated for the possibility of causing 
cholesteryl ester accumulation in endothelial cells. 
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2. EXPERIMENTAL PROCEDURES 
2. l. METHODS 
2.1.1. Cells 
(a) Bovine aortic endothelial cells: A3c1 2 was a clonal 
cell strain derived from the thoracic aorta of a 2-3 
month old bovine embryo, prepared according to the 
method of Ross (137). The foetus, obtained from the 
abattoirs, was kept on ice for about 30 min until the 
aorta was removed. All procedures were carried out 
under sterile conditions. The foetus was washed with 
betadine and the heart was removed with the aorta intact. 
The aorta was then dissected free, cleaned of adherent 
fat, rinsed and placed into a sterile 100 mm Petri dish 
containing phosphate buffered saline, pH 7.4 (PBS). 
With minimal handling, the aorta was cut open longitudin-
ally. A st er i l e s ca 1 p el bl a de was used to 1 i g ht l y 
scrape free the endothelial layer. The blade was 
rinsed into a 35 mm Petri dish containing 2 ml of FCS-
medium (Eagle 1 s minimal essential medium buffered with 
Earle 1 s salts, and containing 10% tryptose phosphate 
broth, 10% heat-inactivated foetal calf serum (FCS), 
6 0 µ g / m l p e n i c i l 1 i n G a n d l O O µ g / m 1 s tr e p to my c i n 
sulphate). The FCS-medium is the normal growth medium. 
The cells were maintained at 37°C in a humidified atmos-
phere (95% air: 5% CO 2 ) until they attached to the dish. 
Clon:L!ul: When the cultures reached confluence, the cells 
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were trypsinized (0.05% trypsin - 0.02% EDTA) and plated 
into 60 mm Petri dishes at a density of 100 - 400 cells/ 
4 ml FCS-medium. The cells were left for 1-2 weeks to 
allow colony formation from single cells. The colonies 
that appeared to be derived from a single cell were 
marked and later harvested using cloning rings. When 
cell growth appeared to be confluent, these cells were 
subdivided for storage under liquid nitrogen. 
Storage and Passaging: Cells were frozen in l ml 
aliquots of FCS-medium containing 10% dimethylsulphoxide 
(OMS O) . The cell concentration was 10 6 cells/ml. When 
required, the frozen cells were thawed in a 37°c water-
bath, with subsequent addition of 5 ml of FCS-medium, 
followed by a low speed centrifugation to remove the 
DMSO. The cells were then resuspended in FCS-medium 
and seeded into a 75 cm 2 flask in a total of 12 ml of 
FCS-medium. After 1-2 weeks when the cells had reached 
confluence, they were dissociated by trypsinization and 
seeded at a plating density of 10 5 cells/4 ml in 60 mm 
Petri di shes. Cells were counted in a Coulter Counter -
Model Zf(Coulter Electronics Inc., Hialeah, Florida). 
These endothelial cells were always used below the 12th 
passage. 
Factor VIII antigen detection: One of the distinguishing 
characteristics of endothelial cells is the presence of 
the glycoprotein, Factor VIII antigen, on the cell surface 
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( 26). This was detected using a fluorescent antibody 
technique as described by Schwartz (19) (Plate 2.1}. 
Cells were grown to confluence on glass coverslips in 
60 mm Petri dishes. These were rinsed with phosphate 
buffered saline containing 2 mM MgC1 2 (PBS-MgC1 2) and 
fixed in acetone for 10 min at o0 c. The coverslips 
were then overlaid with rabbit antibody globulin to 
human factor VIII (AHG) associated protein. The cover-
slips were placed in a humidified incubator (95% air: 
5% CO 2) at 37°C for 30 min. Next they were rinsed in 
PBS-MgC1 2 for 45 min, changing the PBS-MgC1 2 every 15 
min. The coverslips were dried, and fluorescein-con-
jugated goat antibody globulin to rabbit immunoglobulins 
(diluted l :3) was added to the cells on the coverslips. 
The cells were again incubated at 37°c for 30 min, 
followed by a 45 min rinse with PBS-MgC1 2 . Covers lips 
were mounted on microscope slides with the cells face 
down onto a drop of glycerol-PBS, pH 7.6. The edges 
of the coverslips were sealed to the slides with clear 
nail varnish. Controls were carried out in duplicate, 
using either normal rabbit serum or PBS-MgC1 2 in place 
of rabbit antibody globulin to human factor VIII (AHG) 
associated protein. All preparations were examined 
by epifluorescent microscopy, using a Leitz Laborlux 
12 microscope. In the blue light fluorescence system, 
the exciting frequency was 495 nm and the emitted 
frequency was 510 nm. A real suppression barrier 
filter (cut off at 530 nm) was used. Images were 
PLATE 2. 1: FACTOR VIII ANTIGEN DETECTION 
Fluorescent antibody technique performed on bovine aortic 
A. Cells treated with rabbit antibody globulin to human 
factor VIII (AHG) associated protein and exposed to 
FITC-conjugated goat antibody globulin to rabbit 
immunoglobulins. 
B. Cells treated with normal rabbit serum and exposed to 
FITC-conjugated goat antibody globulin to rabb i t immuno-
globulins. 
C. Cells treated with PBS-MgCl 2 and exposed to FI TC-
conjugated goat antib ody glob ulin to rabbit immuno -
globulins . 
Magnification= x480 . 
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recorded on Kodak Tri-X film by a 20 sec exposure under 
standard illumination conditions. 
Gelatin-coated Petri-dishes: Endothelial cells were 
grown on gelatin-coated Petri dishes to obtain a culture 
which exhibited and maintained a confluent monolayer. 
A 1% gelatin solution was made by allowing the gelatin 
to swell at 4°C in distilled water for 30 min . This 
solution was centrifuged and washed 7 times with ice-
cold distilled water at low speed centrifugation 
(1000 x g) for a duration of 15 min each. Finally the 
gelatin pellet was resuspended in the correct volume of 
distilled water and sterilized by boiling for 20 min. 
Each Petri dish was covered with 4 ml of the sterile 
1% gelatin. The excess was removed by aspiration and 
the dishes were allowed to dry overnight in a laminar 
flo w hood. 
(b) Hu man skin fibroblasts: Two receptor normal fibroblast 
cell strains were used, namely GM0203 and SB. GM0203 
was obtained from the Human Genetic Mutant Cell Repository, 
Camden, New Jersey. SB was obtained from a skin biopsy 
from the medial part of the forearm of a male normo-
lipaedimic adult and maintained in culture by the same 
method as described for the bovine endothelial cells. 
These cells were always used between the 10th to 16th 
passage. 
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(c) Macrophages: A continuous cell line (J774) originating 
from cultured murine lymphoblastoid cells having several 
characteristics of macrophages (138) was kindly donated 
by Dr Z. Werb, San Francisco. These cells were stored 
and seeded in the same way as the endothelial cells 
and fibroblasts, but passage number was not recorded. 
2. l .2. Preparation of lipoproteins and lipoprotein-deficient 
serum 
Human LDL (8 = 1.019 - 1.063 g/ml) and human lipoprotein-
deficient serum (8 > 1.25 g/ml) were isolated from the plasma 
of normolipidaemic donors by ultracentrifugat~on, using a 
Beckman L8-70 ultracentrifuge (Beckman Instruments Inc., 
Fulleston, California). Fractions were isolated by dis-
continuous gradient centrifugation using the method of 
Chung et al (139). 
A discontinuous NaCl/KBr density gradient was formed by 
adjusting the density of the plasma (containing 0.01 % EDTA) 
to 1.3 g/ml with solid KBr . The 25 x 89 mm polyallomer 
ultrac~ntrifuge tubes were filled with 13 ml aliquots of 
serum (8 = 1.3 g/ml which were layered carefully under 27 ml 
of 0.9 % NaCl - 0.01 % EDTA, pH 7.0 (8 = 1.006 g/ml). 
Specimens were centrifuged at 50 000 rpm for 2.5 h at 10°c 
in a VTi 50 rotor. The various lipoproteins layered in 
well-defined bands corresponding to their specific density 
ranges (Figure 2. 1). 
FIGURE 2. l: 
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+ VLDL (milky white) 
+ LDL (clear yellow) 
+ HDL (clear orange) 
+ LPDS (clear red) 
Separation of lipoproteins. 
The centrifuge tube was sliced with a tube-cutter (Beckman 
Instruments Inc., Fulleston, California) to recover the LDL 
and the bottom fraction. The LDL fractio n was washed at a 
density of 1.063 g/ml by an overnight centrifugation at 
40 000 rpm in a Ti 60 rotor. The yellow layer at the top 
of the tube which contained LDL was collected. 
The bottom fraction obtained after the initial 2.5 hour cen-
trifugation was adjusted to 1.25 g/ml with solid KBr and 
washed by recentrifugation at 50 000 rpm for 6-8 h in a VTi 50 
rotor. The residual HDL at the top of the tube was removed 
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and the lipoprotein-deficient serum fraction (LPDS) was 
retained. 
Both the LDL and LPDS fractions were dialysed extensively 
against 0.9 % NaCl - 0.01 % EDTA, pH 7.4 at 4°c. They were 
subsequently sterilized by filtration through a Millipore 
filter of 0.45 µm pore diameter. The protein content was 
determined by the method of Lowry et{!_ (140), using bovine 
serum albumin (BSA) as standard. The LPDS was heat-inacti-
vated (56°c, 30 min) and stored at o0 c until required. LDL 
was stored at 4°C and used within a month. 
Preparation of acetylated-LDL: Acetylated-LDL (AcLDL) was 
prepared according to the method of Fraenkel-Conrat (141). 
An ice-cold solution of saturated sodium acetate was added 
to LDL in a 1:1 ratio (v/v), and gently mixed. This was 
then allowed to stand on ice for 5 min, before the addition 
of acetic anhydride. The amount of acetic anhydride used 
was 1 µl acetic anhydride/1 mg LDL. The acetic anhydride 
was added over a period of an hour with mixing on every 
add i tion. The solution was subsequently extensively dialysed 
at 4°c against 0.9 % NaCl - 0.01 % EDTA, pH 7.4, followed by 
a 1 min centrifugation in a Microfuge B (Beckman Instruments, 
Inc., Spinco Division, Palo Alto, California) to remove any 
~; precipitated protein. The protein content, as measured via 
"""-
the Lowry method (140), resulted in a 10-20% loss of lipo-
protein. AcLDL was stored at 4°c and used within 3-4 weeks. 
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Radioactive labelling of lipoproteins: LDL and AcLDL were 
iodinated using the iodine monochloride method of Mcfarlane 
as modified by Bilheimer et~ (142). The lipoprotein 
(10 mg) to be iodinated was placed in a test-tube containing 
glycine buffer, pH 10 (0.3 - 0 . 5 M), and 50 µ1 of 1251-sodium 
iodide (100 mCi/ml; 13-17 mCi/µg). A 4.2 mg/ml solution 
of iodine monochloride was diluted 1:5 with 2 M NaCl. Of 
this solution, 0.4 ml was syringed with a quick and forceful 
action into the mixture contained in the test-tube. The 
resulting solution was then extensively dialysed at 4°c 
against 0.9 % NaCl - 0.01 % EDTA, pH 7·.4, to remove any unbound 
125 1. The label in both LDL and AcLDL was 98% precipitable 
with 5% trichloroacetic acid (TCA), and the lipid radio-
activity as determined by the method of Fol ch~~ (143) 
was approximately 3% in both cases. Using the above proced-
ure to label the lipoproteins, the specific activities of the 
labelled lipoproteins ranged from 160 - 250 cpm/ng protein. 
2 . 1.3. Electrophoretic characterisation of the lipoproteins 
~arose gels: Lipoproteins were separated on preformed 
agarose gels (Beckman Paragon Lipoprotein Electrophoretic kit) 
at pH 8.6. The slab gel was run at 100 mA for 20 min, after 
which it was fixed for 10 min. It was subsequently dried at 
go 0 c (10 min) and stained for 5 min in Lipa stain. The gel 



















PLATE 2.2: AGAROSE GEL SEPARATION OF LIPOPROTEINS 
], 2 = L DL 
3,4 = VL DL 
5,6 = HDL 
7,8 = AcLDL 
9, 1 0 = 125 I-AcLDL 
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SOS-PAGE: Lipoprotein proteins were separated according 
to molecular weight on SDS-polyacrylamide slab gels 
according to the method of Laemmli (144) (Plate 2.3). A 
linear 6-12% polyacrylamide gradient containing glycerol 
(7.5 - 20 %; v/v) was used, with a 5% acrylamide stacking 
gel. Samples of lipoproteins were prepared i~ solubilizing 
buffer (0.062 M Tris-HCl (pH 6.8), 2% SOS and 10% glycerol} 
containing 5% 8-mercaptoethanol to give a final concentration 
of about l mg protein/ml. High and low molecular weight 
standards used were those from Electrophoresis calibration 
kits (Bio-rad Laboratories, Richmond, California). The 
electrode buffer contained 0,025 M Tris-HCl, pH 8.3, 0.1 % 
SOS, 0,02 M glycine and the gel was run at 25 mA for the 
first hour, then at 30 mA until the tracking dye (bromo-
phenol blue) reached the bottom of the gel (about 4 h). 
The gel was stained in 0,025 % Coomassie blue stain in 25% 
isopropyl alcohol and 10% acetic acid. 
solution used was 10% acetic acid. 
The destaining 
2. 1 . 4. Determination of bound, internalized and degraded 
125 I-lipoproteins. 
Unless otherwise stated in the legends, lipoprotein receptor 
activity was up-regulated (145,146) by exposing the endo-
thelial cells to 2 ml of LPDS-medium {Eagle's minimal essen-
tial medium buffered with Earle's salts, and containing 
human LPDS (5 mg protein/ml, i.e. "-10 %), which had been heat-
inactivated, 60 µg/ml penicillin G and 100 µg/ml strepto-
mycin sulphate). The LPDS-medium was changed every 24 h 
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PLATE 2.3: SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS 
l , 2, 3 = 2. 5, 5, 1 0 µ 1 of AcLDL (l mg/ml) 
respectively 
4,5,6,7 = 2. 5, 5, 1 0, 20 µl of LDL ( 1 mg/ml) 
respectively 
8 = high molecular weight standards 
9 = low molecular weight standards 
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when longer incubations were used. 
After upregulation, the cells received 2 ml of fresh LPDS-
medium containing the required amounts of 125 1-labelled 
lipoproteins as specified in Results. (Note~ Throughout 
the text 125 r-labelled lipoproteins are referred to as 
125 I-lipoproteins). The cells were incubated at 37°c 
under humidified conditions (95 % air: 5% CO 2). After 
4 h, the cells were cooled to 4°C and the medium collected 
for the determination of 125 I-1ipoprotein products (115). 
Determination of degraded lipoprotein~: The medium was 
treated with 0.6 ml of 50 % trichloroacetic acid (TCA) to 
obtain a final concentration of 12.5 % TCA. Samples were 
placed at o0 c for 30 min to ensure complete precipitation, 
after which they were centrifuged at 1000 x g for 20 min. 
Any free iodide in the TCA-soluble fraction was converted 
to I 2 by the addition of hydrogen peroxide. The standard 
procedure involved treatment of l ml of the TCA-soluble 
fraction with 20 µ1 of 40 % KI and 50 µl of hydrogen peroxide. 
This was followed by the addition of 2 ml of chloroform to 
extract the 12, and centrifugation at 1000 x g for 15 min. 
An aliquot (750 µ1) of the resulting aqueous phase was 
counted (Packard PGP autogamma (Prias) counter). The counts 
were used to calculate the degradation amounts, which were 
expressed as ng 125 I-lipoprotein protein degraded/mg cell 
protein. Routinely, lipoproteins in LPDS-medium were 
incubated in cell-free dishes. Following incubation, the 
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medium was processed as described above. The radioactivity 
obtained was subtracted from that obtained in the presence 
of cells to correct for any extracellular lipoprotein degra-
dation and/or any acid-soluble material present in the 
125 1 1· t. t· - 1popro e,n prepara ions. 
Determination of bound lipoproteins: Following removal of 
the incubation medium, the cells were washed 4 times with 
3 ml of phosphate-buffered saline containing 0.2 % bovine 
serum albumin (PBS-BSA) and 4 times with 3 ml of PBS to 
remove all unbound radioactivity. All washing was carried 
out in a cold-room at 4°C and all solutions were kept at 0-4°c. 
The standard method employed to release surface-bound 
125 1-
lipoproteins was by the addition of 1 ml of 0.05 % trypsin 
0.02 % EDTA for 20 min at 4°c. During this time all the 
cells were released from the dish. Trypsin was inactivated 
by the addition of l ml of LPDS-medium and the suspended cells 
were centrifuged at 1000 x g for 5-10 min. The supernatant 
was decanted and taken to represent the amount of receptor-
bound 125 1-lipoprotein (116). 
Alternatively, the release of surface-bound material was 
executed using 10 mg/ml of dextran sulphate (or 10 mg/ml 
of sodium heparin) for 60 min at 4°c. The resulting solution 
was analysed for 125 1-radioactivity and taken to represent 
the amount of receptor-bound material. 
Determination of internalized lipoproteins: The cell pellet 
was extracted with a 60 % : 40 % methanol : chloroform mixture 
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and centrifuged at 1000 xg (5-10 min). The supernatant was 
discarded and the pellet dried at 60°c for 15 min. The cell 
pellet was then dissolved in 1 ml of l M NaOH by incubation 
at 37°c overnight. This solution was counted for the amount 
f 125 r d. . ·t d . h . t 11 1 t t o -ra 1oact1v1 y to eterm1ne t e 1n race u ar con en 
f 125I l. t . o - 1popro e1n. The amount of cell protein was deter-
mined using the method of Lowry (140). 
4°c Binding of 125 !-lipoproteins: Cells were up-regulated 
for 48 h in LPDS-medium at 37°c in a humidified incubator 
(95 % air 5% CO 2). Subsequently cells wer
e pre-chilled 
for 10 min at 4°C before the addition of 
125 I-lipoproteins 
in 2 ml of Hepes-medium (Eagle's minimal essential medium 
without bicarbonate, containing 10 mM Hepes buffer, pH 7.4, 
60 µg/ml penicillin G, 100 µg/ml streptomycin sulphate and 
5 mg/ml heat-inactivated human LPDS). All procedures at 
4°C were carried out by placing the cell dishes on steel 
trays in a 4°C cold room. All solutions were cooled to 
4°c prior to use. After incubation for 2 hat 4°C, the 
cells were washed extensively at 4°C as previously described. 
At 4°C no internalization or degradation of 
125 I-lipoproteins 
occurs; therefore the 4°C binding assay measures only surface 
bound lipoproteins (114,147). 
Inhibition of lipoprotein degradation: ln certain experiments, 
known inhibitors of lysosomal activities were used to prevent 
125! 1. . d d . - 1poprote1n egra at,on. Cells were incubated at 37°c 
with LPDS-medium containing 125 I-lipoprotein in the presence 
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of 70 µM chloroquine (148) or 100 µg/ml leupeptin (149). 
The variousprocedures outlined above to determine the amount 
of bound, internalized and degraded lipoproteins were executed 
in each case. 
2. 1.5. Affinity constants and maximum capacity determinations 
Affinity constants and maximum capacity binding of lipo-
proteins to the cell surface can be obtained using the analogy 
of hormone-receptor interactions (150). Assuming that the 
lipoprotein-receptor interaction is a simple bimolecular 
reaction, the following equilibrium equation holds: 
ILi + !RI~, ~-IL - RI k_, 
k 1 . 
' 
\'/here ILi, IRI and IL-RI represent the concentration of lipo-
protein, receptor and receptor-bound lipoprotein respectively. 
The equilibrium dissociation constant (k 0 ) is the ratio of 
the dissociation (k_ 1 ) to the association (k 1) rate constants, 
-1 i.e. (k_ 1.k 1 ). 
Two linearization techniques were employed to calculate the 
apparent equilibrium dissociation constant (k 0 ) and the 
maximum capacity (Vmax) of lipoprotein receptor activity. 
Scatchard Analysis (136) 
The ratio of receptor-bound (V) 
to free lipoprotein(s) was plot-
ted against receptor-bound lipo-







resultant straight line is equal to-}, and the intercept 
cS 
on the x-axis corresponded to the Vmax· This plot is 
weighted for k0 analysis. 
Riggs Analysis (151) 
s 
Free lipoprotein (S) was plotted 
against the ratio of free to 
receptor-bound lipoprotein (V). 
The slope of the resultant 
straight line is the maximum 
lipoprotein bound (Vmax) and 
f- Slope = Vmax 
the point of intersection on the 0 
f<.-. - k 
y-axis is equal to -k 0. 




Rece pt or number per cell: The numbers of receptors per cell 
were determined using the following equations and assumptions: 
no . of recep tors per dish = LDL particles bound per cell at 
saturating concentrations of LDL 
= 
bound LDL protein (g/dish) 
(MW lipoprotein)( % protein in 
x (Avogardo's no.) 
LDL) 
where MW lipoprotein = 2.6 x 106 daltons 
.% protein of LDL = 20 % 
no. of receptors per ce 11 = .(!i_o. of receptors per dish) 
(cells per dish) 
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2. 1.6. Determination of DNA synthesis 
The synthesis of DNA was determined by measuring the amount 
of thymidine lmethy1- 3HI taken up by the cells. The cells 
were incubated with 2 µCi 3H-thymidine in 2 ml of FCS-medium 
at 37°c in a humidified incubator (95 % air : 5% CO 2). After 
one hour, the cells were trypsinized (0.05 % trypsin - 0.02 % 
EDTA) and well aspirated to disperse the cells. An aliquot 
of the cell suspension was counted in a Coulter counter, 
The remaining suspension was precipitated by 50 % TCA to give 
a final concentration of 10% TCA. After mixing, the solution 
was kept at 4°C for 30 min. The TCA-precipitated material 
was filtered under suction onto GF-C millipore filters 
( Wh atman 2.5 glass filters), washed five times with 5% TCA 
and once with 96 % ethanol. The filter was dried at 37°c 
overnight, and subsequently prepared for counting by the 
addition of scintillation fluid (~eckman Ready-Solv™ EP). 
2. 1.7. Determination of ACAT activity 
Preparation of 14 c-oleic acid - BSA complex: Chloroform 
(2 ml) was added to 5.6 mg of oleic acid (corresponding to 
20 µmoles of fatty acid) and 125 µCi of 14 c-oleic acid in 
a glass test-tube. After evaporation of the chloroform 
under nitrogen, 60 µmoles of sodium hydroxide in 1.9 ml of 
0.15 M NaCl were added. The test-tube was heated to boiling 
over a flame with extreme care, after which it was placed in 
a waterbath at 40°C. Bovine serum albumin (340 mg) in 3 ml 
of 0.9 % NaCl - 0.01 % EDTA, pH 7.4, was heated to 40°c in a 
waterbath. The oleic acid solution was added dropwise with 
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a heated pipette to the continually stirred bovine serum 
albumin (BSA) solution. Following the additionof all the 
oleic acid, the solution was then made up to 10 ml with 
pre-warmed (40°C) 0.9% NaCl - 0.01% EDTA, pH 7.4. 
ACAT assay: Cells were up-regulated for 48 h ·in LPDS-medium 
and were then incubated with 200 µg protein/ml of lipoprotein 
in LPDS-medium at 37°C in a humidified incubator (95% air : 
Controls using 10 µg/ml of 25-hydroxycholesterol 
or LPDS-medium alone, were also carried out for each assay. 
After 5 h, 0. l mM 14 c-oleic acid - BSA(~ 15 000 dpm/nmol) 
was added to each of the dishes, which were returned to the 
incubator. After 2 h the cells were thoroughly washed three 
times with 3 ml of phosphate buffered saline, followed by a 
60 % 40 % methanol chloroform extraction. 
was then centrifuged at 1000 x g for 20 min . 
The suspension 
The supernatant 
was poured off into glass test-tubes and the pellet was dried 
at 60°c for 15 min. Subsequently, 1 ml of 1 M NaOH was added 
to the pellet, and was left at 37°C overnight. This solution 
was then used for protein determination via the Lowry method 
(140). Chloroform (2.5 ml) and 0.04% CaC1 2 (1.5 ml) was 
added to the supernatant and the solution was mixed and then 
centrifuged at 1000 x g. The upper aqueous layer was removed 
by aspiration and discarded. Methanol was added dropwise to 
the organic layer until clear, and this solution was then 
dried under nitrogen. Each sample was resuspended in 50 µl 
of cholesterol ester (triolein) (1 mg/ml) and 50 µl of tri-
"- .,._ ____. 
glyceride (1 mg/ml), and spotted onto thin layer chromatography 
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? 
plates. The samµ,le runs with the solvent front. 
./'- --- "'-- The 
solvent is a mixture of 170 ml hexane, 30 ml diethyl ether 
and 2 ml acetic acid. · The plates are cut up and transferred 
to scintillation vials containing scintillation fluid (Ready-
Solv TM EP, Beckman). 
Beckman LS 9000 counter. 
Subsequently they are counted in the 
2. 1.8. Determination of free and total cholesterol 
The amount of free and total cholesterol present in the cells 
was determined according to the method of Gamble et al. (152). 
Cultured cells that had been incubated with either LDL or 
AcLDL were washed and harvested as in the ACAT assay (see 
Methods 2.1.7). The pellet was used for protein determination. 
Once this had been established, the supernatant was aliquoted 
into test-tubes. Standard solutions of 0.1 mg/ml cholesterol 
were distributed into test-tubes to yield standard curves 
(see Figure 2.1). The chloroform present in the various 
samples was evaporated under nitrogen, after which the samples 
were heated for a further 20 minutes at 105°c. To each test-
tube, 200 µ1 of 95 % ethanol was added, as well as 2 ml of 
premix 1 to the cholesteryl oleate standards and samples, and 
· 2 ml of premix 2 to the cholesterol standards and samples. 
Premix 1 consists of 845 µ1 of 0. l M potassium phosphate 
buffer, pH 7.4; 210 µl of l U/ml cholesterol oxidase; 10 µl 
10 µ1/ml peroxidase (horse radish); 0.5 U/ml cholesterol 
esterase; 105 µ1 of 0.5 % Triton X-100; 20 mM sodium cho1ate; 
and 315 µl of 4 mg/ml p-hydroxyphenylacetic acid. Premix 2 
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FIGURE 2. 1: STANDARD CURVES OF FREE AND TOTAL CHOLESTEROL --~--
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was omitted and the equivalent amount of potassium phosphate 
buffer was added. All the enzymes were made up in buffer. 
Once the premixes were added to the correct samples, the 
test-tubes were placed in a waterbath at 37°c for an hour. 
The fluorescence was measured at an excitation wavelength of 
324 nm and at an emitter wavelength of 415 nm on a Perkin 
Elmer 203 fluorescence spectrophot-0meter. 
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3. 1. ENDOTHELIAL CELL CULTURE 
The cells chosen for this study were bovine aortic endothelial 
cells, which were isolated by mechanical scraping of the lumen 
of the aorta of a bovine foetus, and which weie subsequently 
3.1.l. Morphology of cultured cells on different substrates 
Endothelial cells~ vivo are characterized by the formation 
of a monolayer of flat, polygonal cells which are contact-
inhibite d . Although it has been relatively easy to isolate 
and grow endothelial cells in culture, the maintenance of a 
contact-in hibited monolayer has proved to be more difficult. 
Hence, various substrates and agents have been employed to 
establish a cell monolayer resembling the in vivo morphology 
at post-confluence (see Introduction 1.2). 
In this study, a comparison of cells grown on gelatin-coated 
Petri dishes to cells grown on uncoated plastic Petri dishes 
5 
w a s made ( P 1 ate 3 . 1 ) . The c e 11 s seeded at 1 0 c el 1 s / 6 0 mm 
dish were sparsely distributed during the first 3 days. The 
plating efficiency was about 98 %'. These epithelioid cells 
with radiating protrusions were found in a number of foci on 
the dishes, which eventually converged to form a monolayer of 
polygonal cells. This sheet of cells, having a cobblestone 
appearance, had been formed by day 6. Thereafter, the cells 
PLATE 3.1: CULTURED BOVINE AORTIC ENDOTHELIAL CELLS 
Bovine aortic endothelial cells (A 3c1 2 ) were seeded at 
10 5 cells/60 mm Petri dish on day O in 4 ml of FCS-medium. 
The cells recei ved fresh medium every 3-4 days. 
A-D: Subconfluent layer of cells (day 1, 2, 3, 5 respectively 
showing rapid proliferation of cells to confluence. 
E: Confluent monolayer of cells (day 10) grown on gelatin-
coated Petri-dishes. 
F: Multilayer of cells (day 10) grown on plastic Petri-
dishes. 
G: Post-confluent layer of cells. (day 14) grown on gelatin-
coated Petri-dishes showinij a small percentage of 
11 sprouters 11 • 
H; Confluent layer of cells treated with 70 µM chloroquine 
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grown on gelatin-coated dishes formed a tight monolayer 
of small round cells, whereas those grown on plastic dishes 
failed to maintain a contact-inhibited monolayer, and multi-
layered in random directions. The monolayer on gelatin-
coated dishes could be maintained for about 10-12 days, after 
which 11 sprouters 11 appeared. These II sprout er s II are f us i f o r·m 
cells connected end-to-end, which have been shown to grow in 
focal areas as a single layer beneath the monolayer (19,43). 
The 11 sprouters 11 appear to proliferate to a limited extent, 
giving rise to a small number of cells (less than 1% of the 
· total number of cells), even when cultures were maintained 
for 3 weeks. 
In most subsequent experiments, cells were therefore cultured 
on gelatin-coated dishes because of their closer resemblance 
to the monolayer found in vivo. Sparse cultures were used 
in experiments before day 6 and confluent cultures were used 
between day 9 and day 12 to avoid the presence of sprouting 
cells. 
3. l. 2. Comparison of growth rate 
Since the morphology of A3c1 2 differed, depending on the 
substrate to which they adhered, it was of interest to study 
the growth rate of the two cultures. This was done by inves-
tigating the protein content, number of cells and 3H-thymidine 
incorporation with increasing age of culture. 
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FIGURE 3. l: PROTEIN CONTENT IN ENDOTHELIAL CELLS WITH 
INCREASING AGE OF CULTURE. 
Endothelial cells (A 3cl 2) were plated
 at a seeding density 
of 10 5 cells/60 mm dish on day 0, and grown in FCS-medium on 
either gelatin-coated (.__.) or uncoated plastic (o--o) 
dishes. On each specified day, the protein content was 
determined. The medium was changed every 3 days. Each 
point is the mean value obtained from duplicate dishes. 
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intervals in cultures of increasing age (Figure 3. 1). It 
was found that the cells grown on gelatin-coated dishes 
showed little protein content increase once a monolayer of 
cells had been formed. In contrast, cultures grown on 
plastic showed a continued steady increase in protein con-
tent, as would be expected with the formation of multilayers. 
A similar pattern was observed when the number of cells per 
dish was determined in cultures of increasing age (Figure 
3. 2. A). The number of cells grown on gelatin-coated or 
plastic dishes did not differ substantially in sub-confluent 
cultures. However, once confluence had been attained, the 
number of cells grown on gelatin-coated dishes did not 
increase, reflecting a tight monolayer of cells . On the other 
hand, the number of cells grown on plastic continued increas-
ing with days in culture, reflecting the multi-layering 
nature of A3c1 2 on plastic. 
In the same experiment, in which the cell numbers per dish 
were determined, the incorporation of 3H-thymidine was 
measured. This was used as an indication of DNA synthesis 
occurring in dividing cells. In contrast to the difference 
observed in the number of cells per dish in the two cultures, 
the incorporation of 3H-thymidine did not differ. In both 
ca s e s , th e i n c o r po r a t i on d e c re a s e d by a b o u t 9 O % from day 1 to 
day 10 (Figure 3.2.B). 
It may have been expected from the previous data that the 
FIGURE 3.2: CELL NUMBER AND 3H-THYMIDINE INCORPORATION IN 
ENDOTHELIAL CELLS WITH INCREASING AGE OF CULTURE 
Endothelial cells (A 3c1 2) were seeded at 10
5 cells/60 mm dish 
on day 0, and grown in FCS-medium on either gelatin-coated 
(e---e) or uncoated plastic (o---o) dishes. On the specified 
day, the cells were incubated with 2 µCi 3H-thymidine in 2 ml 
of FCS-medium for l h. The medium was discarded and the 
remaining cells were trypsinized with 0.05% trypsin - 0.02% 
E OTA. 
A: An aliquot of the cell suspension was used to determine 
the cell number by counting the cells in a Coulter 
counter. 
B: The remaining cell suspension was precipitated with tri-
chloroacetic acid (final concentration of 10%) and the 
radioactivity in the protein pellet was counted as a 
measure of 3H-thymidine incorporation. 
Each point represents the mean value obtained from duplicate 
dishes. 
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post-confluent multilayered culture (grown on uncoated 
plastic) would exhibit greater 3H-thymidine incorporation 
than the post-confluent monolayer (grown on gelatin-coated 
dishes). However, 3H-thymidine incorporation need not be 
an accurate reflection of DNA synthesis and thus replication 
of the cells. In addition, the method employed to measure 
3H-thymidine incorporation may not have beensensitive enough 
to distinguish between a 10 % difference in proliferation 
rates of the cultures, once confluence had been attained. 
An alternative explanation could be that the monolayered 
culture was still dividing, with some cells being released 
into t he medium rather than re maining attached to the substrate. 
For this reason, the medium of duplicate dishes in each culture 
was collected and counted on the specified days (Table 3.1). 
The nu mb er of cells released into the medium were expressed 
as a percentage of the total nu mber of cells that remained 
attac hed in each dish. All the dishes received fresh medium 
every day. The number of cells found in the medium on the 
first da y was l .7 % for cells gro0 n on gelatin-coated dishes 
and 1. 3% for those grown on plastic dishes. Thereafter, 
the num ber of cells released in each 24 h period was consis-
tently less than 1% of those attached to the dish. As can 
be seen in Table 3. 1, the number of cells released by cell 
cultures on gelatin-coated dishes are similar to the number 
released by the cell cultures on plastic dishes. It would 
therefore appear that the difference in the growth of the two 
cultures was merely not the result of a difference in the 





































































































































































































































































































































































































































































































































































































that the cells grown on gelatin-coated dishes had a slower 
division rate than those grown on uncoated plastic dishes. 
The observation that 3H-thymidine incorporation did not 
decrease to zero in confluent cultures has also been 
observed by Gimbrone et~ (153). These authors obtained 
a 90 % decrease from a day 2-3 culture to a dense monolayer 
of human umbilical vein endothelial cells. The 10% 
3H-thymidine incorporation is most likely a reflection of 
residual radioactivity in the cells rather than an indica-
tion of replication. Theincrease observed after day 10 
could possibly be due to the appearance of "sprouters 11 in 
the culture grown on gelatin-coated dishes. However, as 
mentioned earlier, 11 sprouters 11 were almost absent in con-
fluent cultures up to day 10-12, and even thereafter com-
prised less than 1% of the total number of cells per dish. 
Another situation which could lead to an increased incorpora-
tion of 3H-thymidine would be the peeling of the cell layer, 
with the subsequent proliferation of cells. This phenomenon, 
which has been found to occur in vitro after an injury of the 
endothelial layer, however, did not occur in this case. 
3.2. VALIDATION OF EXPERIMENTAL PROCEDURES 
321 125 11· . b"d" . . . · - 1poprote1n ,n 1ng 
Washing of cells: After incubating cells with 125 1-lipo-
proteins, it is important to remove the medium containing 
unbound radioactive material, to obtain a more accurate 
67 
value of bound 125 I-lipoproteins. This was done by sequen-
tial washing of the cells. Goldstein et al (114) investi-
gated the number of washes required to remove unbound radio-
active medium from fibroblasts and concluded that 8 washes 
were sufficient. The number of cell washes required could 
perhaps differ between different cell types and therefore 
this was investigated with endothelial cells (A 3c1 2 ), using 
normal human skin fibroblasts (GM 0203) as a comparison. 
The cells were incubated with either 125 r-LDL or 1
25 r-AcLDL 
in LPDS-medium at 37°c for 4 h or in Hepes-medium at 4°C 
for 2 h. The two different temperatures were studied, 
since it was of interest to perform future experiments at 
both these temperatures. 
The cells which had been incubated with the 
125 I-lipoprotein 
at 4°c for 2 h received 12 sequential washes with phosphate 
buffered saline containing 0.2 % bovine serum albumin (PBS-BSA) 
followed by 4 washes with phosphate buffered saline (PBS) 
(Figure 3.3). Each wash was collected and counted for radio-
a ct i vi ty. When cells were incubated with 125 -lipoproteins 
at 37°c for 4 h, · they were first cooled to 4°c, and then 
washed at this temperature. This temperature was employed 
t t f 1251 1 · t . t' 11 o prevent movemen o - 1popro e1ns across ne ce 
membrane. A washing procedure of 8 sequential washes with 
PBS-BSA followed by 2 washes with PBS was used (Figure 3.4). 
At both temperatures recovery of unbound material appeared 
complete after about 6 to 8 washes. Since a long washing 
procedure could possibly result in dissociation of some bound 
material, it was decided to use a total of 8 washes (4 PBS-BSA; 
FIGURE 3. 3: CELL WASHES AFTER 125 I-LIPOPROTEIN BINDING 
AT 4°C 
On day 3, endothelial ce1ls which had not been up-regulated, 
were incubated for 2 h at 4°c with 2 ml of Hepes-medium con-
taining either 10 µg protein/ml 125 I-LDL {A) or 10 µg protein/ 
ml 125 I-AcLDL (B). Similarly, on day 6, human skin fibro-
blasti (GM0203) which had been up-regulated for 48 h with 
LPDS-medium, were exposed to 10 µg protein/ml 125 I-LDL (C). 
Subsequently, the medium was removed and the radioactivity 
counted. Each dish was then washed sequentially 12 times 
with 3 ml of phosphate buffered saline containing 0.2 % 
bovine serum albumin (PBS-BSA) and 4 times with 3 ml of 
phosphate buffered saline (PBS). Each wash was collected 
and the radioactivity was counted. The dotted line 
represents the background count of the counter. 
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FIGURE 3.4: CELL WASHES AFTER 125 I-LIPOPROTEIN BINDING 
AT 37°c 
On day 3, endothelial cells (A 3c1 2) which had not been up-
regulated, were incubated at 37°c for 4 h with 2 ml of 
LPDS-medium containing either 10 µg protein/ml of 125 r-LDL 
{A} or 10 µg protein/ml 125 I-AcLDL (B). · Similarly, on 
day 6, human skin fibroblasts {GM0203), which had been up-
regulated for 48 h in LPDS-medium, were exposed to 10 µg 
protein/ml 125 1-LDL. After the 4 h incubation, the cells 
were cooled to 4°c and the medium collected and the radio-
activity counted. Subsequently, the cells were sequen-
tially washed 8 times with 3 ml of phosphate buffered saline 
containing 0.2 % bovine serum albumin and twice with 3 ml of 
pho sphate buffered saline. 
radioact i vity was counted. 
Each wash was collected and the 
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4 PBS) in future experiments. 
Release of bound material: The release of bound 1
25 I-lipo-
proteins was studied using 3 different agents, namely, hepa-
rin, dextran sulphate and trypsin, to dissociate ligand from 
cells. Binding at 4°C was investigated because it has been 
shown that lipoproteins at this temperature are bound to 
cells, but not internalized (114). 
Initially a comparison of rel~ase of bound 125 1-lipoproteins 
with time was studied using dextran sulphate and trypsin 
(Table 3.2). The standard procedure involved the incubation 
of endothelial cells with 125 I-lipoproteins for 2 h at 4°C, 
followed by 8 washes with PBS-BSA and PBS. Thereafter, the 
cells were incubated for different time intervals with either 
trypsin or dextran sulphate. This solution was then callee-
ted, and the radioactivity counted and compared to the radio-
activity remaining associated with the cells. From the 
data obtained, it could be concluded that a 20 min incubation 
with trypsin was sufficient to maximally release bound 125 1-
lipoproteins. A 20 min incubation with trypsin released 
81 % of 125 I-LDL and 68 % of 125 1-AcLDL initially bound to the 
cells. At this stage all the cells had detached from the 
dish. The generally used incubation time period of cells 
with dextran sulphate resulted in a release of 60% of the 
total amount of bound 125 I-AcLDL after 60 mins, which did not 
increase substantialfy with a longer incubation period. How-
ever, the release of the total amount of bound 125 I-LOL after 
















































































































































































































































































































































































































































































































































































































































































































with this latter time period, the release of bound 
125 1-LDL 
was less than that released by trypsin. 
by 
In order to further investigate the release of trypsin, it 
was of interest to see whether cells incubated at 37°c with 
trypsin would release more bound 125 1-lipoprotein than~ 4°c 
incubation with trypsin (Table 3.3). The possibility of 
internalization of 125 I-lipoproteins at 37°c had to be con-
sidered, and thus a short incubation period would be ~refer-
able. After 5 min at 37°c with trypsin, 51 % of 125 1-AcLDL 
and 80 % of 125 1-LOL of the total amount bound lipoprotein 
had been released. The amount released did not change sub-
stantially in the next 30 min. Since the release of bound 
125 I-lipoproteins was not improved in comparisonto the release 
at 4°C, this method was not used in future experiments. 
A comparison of the release of the total amount of bound 
125 1-lipoproteins by the three agents, trypsin, heparin and 
dextran sulphate, is shown in Table 3.4. Similar results 
to those shown in Table 3.2 were obtained in the case of 
trypsin and dextran sulphate. The release of bound material 
by heparin was similar to that of dextran sulphate, but less 
than that of trypsin. This was more markedly observed with 
the release of 10 µg/ml of 125 I-lipoproteins bound than 
20 µg/ml of 125 I-lipoproteins bound. For example, at 10 µ9/ 
ml dextran sulphate and heparin released about 30% of 
125 1-
AcLDL bound and trypsin released about 70%. The situation 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































same various conditions, the percentage release of bound 
125 1-LDL was larger than that of bound 125 1-AcLDL. 
At this stage it was decided to determine how much of the 
total amount of released 125 1-lipoproteins was actually 
bound by a saturable, high-affinity process, i.e. material 
bound to high-affinity receptor sites which recognize and 
bind the protein moiety of the lipoproteins. Saturable, 
high-affinity binding was calculated from the difference 
between the values obtained in the presence or absence of 
unlabelled lipoproteins. In Table 3.4, a iomparison has 
been made of the percentage of total and receptor-b~und 
125 1-lipoproteins released by either trypsin, heparin or 
dextran sulphate. In all cases, the percentage release of 
receptor-bound (high-affinity) 125 1-LDL was larger than that 
of 125 1-AcLDL (the absolute amounts of labelled lipoproteins 
released from high-affinity sites are shown in Table 3.7). 
This could possibly be a reflection from the observation that 
the percentage release of receptor-bound LDL to non-receptor 
bound LDL was between 40-60%, while the percentage release of 
receptor-bound AcLDL to non-receptor - bound AcLDL was only 
30-40 %. Furthermore, it was observed that when 20 µg protein/ 
1 125 1 l · t · b d t th 11 th t m - 1popro e,ns were oun o e ce s, e percen age 
release from high-affinity sites was more than when 10 µg 
protein/ml 125 I-lipoproteins were bound to the cells. For 
example, in the case of trypsin, upon incubation of the cells 
with 10 µg protein/ml of 1251-AcLDL, the percentage release 
from high-affinity sites was about 35% and with 20 µg protein/ 
76 
ml of 125 r-AcLDL the percentage release was about 55%. 
Similarly for LDL, upon incubation of the cells with 10 µg 
protein/ml of 125 r-LDL, the percentage release was about 
60 %, while at 20 µg protein/ml of 125 I-LDL, the percentage 
release was about 80%. The difference between the percen-
tage release of 10 µg protein/ml and 20 µg protein/ml of 
b d 125 1 1 · t · · . t t "th t 1 oun - 1popro e1ns 1s cons,s en w, a grea er re ease 
of material bound to sites other than high-affinity receptors. 
In view of the above findings, most of the subsequent experi-
ments made use of cells incubated with 20 µg protein/ml 
125 1 l. t . d t . d t l b d - 1popro e,ns an ryps,n was use ore ease oun 
material. 
3 2 2 125 1 l · t . d d t· . . . - 1popro e1n egra a ,on 
Deiodination: Since the measure of degradation is dependent 
on the determination of 125 1-apolipoprotein B degradation 
products, which are mostly in the form of monoiodotyrosine 
(154), the amount of deiodination which might be occurring 
was studied, as any free-iodide is not taken for measurement 
(free-iodide present in the process of labelling the lipo-
proteins would result in a very large background value). 
Deiodination of tyrosine residues could possibly occur before 
or after degradation of the 125 I-lipoproteins has taken place 
in the lysosomes. Chloroquine, which prevents lipoprotein 
degradation (see Results 3.3.5), was used as a means of deter-
mining at what stage deiodination was occurring. 
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After cells were incubated with 125 I-lipoproteins at 37°C 
for 4 h, the protein in the medium was precipitatea with 
trichloroacetic acid (TCA). The TCA-soluble fraction rep-
resented both the free-iodide and the non-iodide material 
· (Table 3.5). The non-iodide material was determined by 
converting the free-iodide to 12 by the additi.on of hydrogen 
peroxide via the standard method (see Methods 2.1.4). When 
the cells had been incubated for 4 h with 125 I-LDL, the amount 
of free-iodide obtained in the TCA-soluble fraction was 26% 
of the total amount of radioactivity determined in this frac-
tion. Similarly, when cells had been incubated with 125 1-
AcLDL, the amount of free-iodide was 32% of the total amount 
of radioactivity in the TCA-soluble fraction. 
Under the same experimental conditions, but in the presence 
of chloroquine, no TCA-soluble counts were obtained. This 
could possibly be explained by two phenomena: either that 
chloroquine inhibits deiodinase activity, or else deiodination 
occurs only once degradation products have been formed. If 
the latter were the case, then the amount of degradation meas-
ured would be an underestimation of the true values. 
3.2.3. Incubation time courses 
To learn more about the metabolism of lipoproteins in endo-
thelial cells, the kinetics of cell uptake and degradation 
of lipoproteins was determined at either 37°C or 4°C. Hence, 
the cells were incubated with lipoproteins for increasing 


















































































































































































































































































































































































































































































































































































state was reflected by the levelling off of b~und or cell-
associated material. 
At 37°C: Endothelial cells were incubated at 37°C for vary-
. l th f t· "th 10 t . / l 125 1 1 · t · 1ng eng so ,mew, µg pro e,n m - 1popro e,n 
in LPDS-medium (Figure 3.5A). The amount of cell-associated 
125 I-LDL reached a plateau by about 2 h, and proceeded to 
decrease rather rapidly thereafter, exhibiting a 76% drop 
from 4 h to 24 h. In contrast, the amount of cell-associated 
125 1-AcLDL reached and maintained a plateau between 20 min 
and 2 h, and dropped by only 19% from 4 h to 24 h. The dec-
line in 125 I-lipoprotein associated material could be due to 
the down-regulation of the receptors. The greater drop in 
125 I-LDL compared to 125 1-AcLDL cell-associated material was 
consistent with results obtained regarding receptor regula-
tion, which showed that the LDL receptor was far more suscep-
tible to regulation than the receptor for AcLDL (see Results 
3. 3. 3). 
There was an initial lag of approximately 30 min before the 
amounts of 125 I-LDL and 125 I-AcLDL degraded, increased at 
a linear rate (Figure 3.58). The rate of degradation (given 
in all following experiments as ng lipoprotein/mg cell protein/ 
4 h) therefore tends to underestimate the actual degradation 
rate. However, the degree of underestimation is small. For 
example, the rates calculated by measuring the total amount 
of degradation over the first 4 h period were 117 ng 
125 1-
AcLDL/mg cell protein/hand 243 ng 
125 I-LDL/mg cell protein/h, 
whereas the rates calculated from the degradation occurring 
during the last 3.5 h period of the 4 h incubation were 
FIGURE 3.5: INCUBATION OF ENDOTHELIAL CELLS WITH 125 I-
L I P OP ROTE IN S AS A FUN CT I ON OF T IM E AT 3 7 o C 
Endothelial cells were pre-treated with LPDS-medium for 48 h. 
On day 5, they were incubated at 37°c with LPDS-medium con-
taining 10 µg protein/ml of 125 I-AcLDL (open markings) and 
125 I-LDL (closed markings), for the specified times. 
A. After removal of the medium, the cells were washed and 
then dissolved in l ml of l M NaOH overnight at 37°c 
( s e e Me th o d s 2 . l . 4 ) . Th e rad i o a ct i v i ty ob ta i n e d i n th i s 
solution was taken to represent cell-associated 125 I-
lipoproteins. 
B. After the various times of incubation, the medium on 
the cells was collected and precipitated with trichloro-
acetic acid (TCA). The TCA-soluble material was treated 
with potassium iodide and hydrogen peroxide, followed by 
a chloroform extraction. The radioactivity in the 
aqueous layer was counted as a measure of degraded 125 I-
lipoproteins. 
In each case, an expanded scale from O - 4 h has been shown. 
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113 ng 125 I-AcLDL/mg cell protein/hand 240 ng 125 I-LDL/mg 
cell protein/h. Degradation rates were thus underestimated 
by 3.4% and 4.2% in the case of AcLDL and LDL, respectively. 
In all future experiments, cells were incubated at 37°c with 
125 I-lipoproteins for 4 h. This time period was chosen as 
it allowed for a relatively substantial amount of degradation 
products to form, which thus allowed for a sensitive and 
accurate assay. Although a longer time period resulted in 
increasing amounts of degradation products, it could be seen 
that longer periods resulted in a significant down-regulation 
of receptors (Fig. 3.5A). 
At 4°C: Endothel~al cells (A 3c1 2) were incubated at 4°C for 
varying time intervals in Hepes-medium containing 10 µg 
protein/ml of 125 I-lipoproteins in the presence or absence 
of 200 µg protein/ml of unlabelled lipoprotein. The amounts 
of receptor-bound lipoproteins were calculatedas previously 
described (see Results 3.2.1) . It was found that .a plateau 
was obtained after about 1 h for both 
125 I-LDL and 125 I-
AcLDL (Figure 3.6). Only a slight increase (10-20%) 
occurred with a further incubation to 2 h. To ensure that 
binding of lipoproteins at 4°C had reached saturation, all 
future experiments were performed using a 2 h incubation 
period. Longer incubation periods, as studied at 37°C, were 
not investigated as the cells are not favourably disposed to 


















































FIGURE 3.6: HIGH AFFINITY BINDING OF 125 I-LIPOPROTEINS AS A 
FUNCTION OF INCUBATION TIME AT 4°c 
On day 2, endothelial cells (A 3c1 2) were incubated at 4°C for 
increasing time periods with 2 ml of Hepes-medium containing 
either 10 µg protein/ml of 125 I-LDL (.__.) or 125 I-AcLOL 
(o---o) in the absence or presence of 200 µg protein/ml of 
unlabelled LOL or AcLOL respectively. After the specified 
times, the medium was discarded and the cells were washed with 
PBS-BSA and PBS (see Methods 2 .1 .4). The amounts of bound 
125 I-lipoproteins were released by incubating the cells for 
20 min with 0.05 % trypsin - 0.02 % EOTA. High affinity 
binding was taken to be the difference between the values 
obtained in the absence and presence of unlabelled lipoproteins. 
Each point represents the mean value obtained from duplicate 
dishes. 
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3.3. CHARACTERISTICS OF ENDOTHELIAL CELLLIPOPROTEIN RECEPTORS 
3.3. 1. Receptor affinity and capacity for lipoproteins 
The affinity and capacity of receptors for LOL and AcLOL 
in endothelial cells was investigated at both 37°c and 4°c. 
At 37°C: The receptor affinity of the cells (A 3c1 2) for LDL 
and AcLDL was determined by incubating the cells with in-
creasing amounts of 125 I-lipoproteins in LPDS-medium at 37°c. 
After a 4 h incubation, the medium was removed for determina-
tion of non-iodide TCA-soluble 125 I-degraded products (see 
Methods 2.1.4). After washing the cells, the amount of 
125 1 ,. t . b d t th 11 l db 20 - 1popro e1ns oun o e ce s was re ease ya min 
incubation at 4°C with 0.05 % trypsin - 0.02% EDTA. The 
radioactivity in the trypsin supernatant was determined as a 
measure of bound 125 I-lipoprotein, and the radioactivity 
remaining associated with the cells was taken as the intra-
cellular 125 I-lipoproteins. 
The resulting quantities of bound, internalized and degraded 
125 1-lipoproteins were represented by two-component curves 
(Figure 3.7). This indicates the involvement of both a 
receptor-mediated (saturable) and non-receptor-mediated 
(non-saturable) processing of 125 I-LOL and 125 1-AcLDL by 
endothelial cells. The saturable, high-affinity component 
of the curve was obtained by subtracting from each lipoprotein 
concentration on the experimental curve, the corresponding 
non-saturable, low-affinity component value. The non-
FIGURE 3.7: BINDING, INTERNALIZATION AND DEGRADATION OF 
125 I-LIPOPROTEINS AT 37°C 
Endothelial cells (A 3c1 2) were pre-treated with LPDS-medium 
for 48 h. On day 9, the cells were incubated with 2 ml of 
LPDS-medium containing increasing concentrations of 125 I-LDL 
(e---e) and 125 I-AcLDL (o--o) at 37°c. After 4 h, the cells 
were cooled to 4°c and the medium removed and analysed for 
degradation products. The cells were extensively washed 
and incubated for 20 min at 4°c with 0.05% trypsin - 0.02% 
EDTA to remove bound 125 I-lipoproteins. The remaining cell 
pellet was analysed for internalized 125 I-lipoproteins, and 
ptotein content. 
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saturable component was derived from the linear portion of 
the curve at the higher lipoprotein concentrations. The 
saturation curve was used for Scatchard {136) and Riggs {151) 
analyses of the equilibrium dissociation constants {k 0
) and 
maximal capacity values (Vmax) respectively (see Methods 
2.1.5). 
In Figure 3.78, it was observed that the binding curve for 
AcLDL had a relatively large non-saturable, high-affinity 
component. Considering the values found for intracellular 
amounts and degradation rates, it is evident that AcLDL was 
taken up and catabolized largely by a high-affinity process. 
Thus, an experiment in which lower concentrationsof 
125 I-AcLDL 
were added to the medium was performed to obtain a more accur-
ate equilibrium dissociation constant (Figure 3.8). Generally, 
a k0 value is 
obtained from the affinity of the lipoprotein 
for its receptor (i.e. binding data). However, since the 
intracellular content and degradation rates depend on and 
reflect the lipoprotein binding as a result of the saturable 
process, the k0 values were alter
natively calculated from the 
saturation curves obtained for intracellular levels and degra-
dation of the lipoproteins. As can be seen in Figure 3.8A, 
the binding curve again showed a very large non-saturable 
component which tended to mask the saturable high-affinity 
component. However, the intracellular and degradation curves 
provided no such problem, and were in agreement with Figure 
3.7B, in that the receptor affinity for AcLDL was very high. 
FIGURE 3.8: BINDING, INTERNALIZATION AND DEGRADATION OF 
125 r-AcLDL AT 37°c 
Endothelial cells were pre-treated with LPDS-medium for 
48 h. On day 8, they were incubated at 37°c with 2 ml of 
LPDS-medium containing increasing concentrations of 125 r-
AcLDL. The amount of bound, internalized and degraded 
125 1-AcLDL was determined as described in Methods 2. 1.4. 
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A number of experiments were performed in order to obtain 
kc values for the affinity at 37°c of receptors on endothelial 
cells for LDL and AcLDL (Table 3.6). The half-maximal values 
obtained for LDL binding, intracellular contentand degradation 
rates were all in the range of 22-32 µg LDL protein/ml. In 
contrast, the processing of AcLDL showed considerable vari-
ab i l i ty. The half-maximal values ranged from 1.77 to 5.58 µg 
AcLDL protein/ml, using degradation and binding data respec-
tively. This difference in half-maximal values could possibly 
be due to the large non-saturable binding component which 
prevents an accurate estimation of the saturable high-affinity 
component. For example, the three experiments (Expts, 5, 6b 
and 7) in which kc values were determined using the binding 
. 
data, the degree of accuracy is questionable, as a slight 
variation in the slope of the non-saturable component would 
result in a large difference in kc values. In contrast, the 
range of kc values obtained from intracellular content curves 
of AcLDL, the values were rather similar with an average kc 
value of 2.99 + 0.44 µg protein/ml. However, in obtaining 
degradation saturation curves for AcLDL, a problem arose in 
two experiments (Expts 5 and 6a). As described in Methods 
2. 1.4, to obtain degradation values, controls of empty dishes 
with the labelled lipoprotein were used to control for cell 
independent breakdown products present in the 
125 I-lipoprotein 
before use. In these two cases, the control values were 
somewhat higher than usual, so that at higher concentrations 
of 125 1-AcLDL a relatively small error in the control value 
























































































































































































































































































































































































































































































































































































































































































































































Reliable k 0 determinations were not possible from thes
e 
values and are therefore not shown. In the degradation 
curves used to obtain k0 values, the duplicates did not vary 
by more than 10%. The half-maximal values obtained were 
between 0.66 and 2.76 µg protein/ml. Expts. 6b and 7 were 
the only experiments in which a complete set of half-maximal 
values (i.e. binding, intracellular and degradation) for 
AcLDL was obtained. It can be seen that in these cases, the 
half-maximal values are similar for the three different para-
meters. However, because of the possible inaccuracies in 
obtaining half-maximal values from the binding saturable 
curves, degradation data are more likely to be a true reflec-
tion of the k0 value. 
LDL, on the other hand, had similar half-maximal values, ob-
tained from either binding, intracellular or degradation 
data. The average k0 value obtained from binding data was 
about 32 µg protein/ml, while the average half-maximal 
values obtained from intracellular and degradation data were 
28 and 22 µg protein/ml, respectively. Regardless of the 
variability in the half-maximal values obtained for AcLDL, 
it can be concluded that endothelial cells have a higher 
affinity at 37°c for AcLDL (k0 ~ 2-5 µg protein/ml) than for 
LDL (k0 ~ 20-30 µg protein/ml). 
The maximum number of receptors (Vmax) for LDL as determined 
by all three parameters in sparse cultures, was found to be 
lower if the cellshad not been up-regulated (up-regulation 
91 
has been further examined in Results 3.3.3). In comparing 
the Vmax for LDL in sparse and confluent up~regulated cul-
tures, it was found in this one experiment {Expt. 2a and 2b) 
that the values for each parameter were very similar, being 
only slightly less in confluent cultures. However, in sub-
sequent experiments (see Table 3.7), it has been consistently 
found that sparse cultures catabolize more LDL than confluent 
cultures. The similarity in this experiment of the Vmax 
for LDL in sparse and confluent cultures cannot be explained. 
In contrast to LDL, the Vmax for AcLDL was not affected by 
up-regulation. However, the Vmax for AcLDL in up-regulated 
cultures was found to be lower in sparse cultures than in 
confluent cultures. These results are consistent with the 
findings presented in Results 3.3.2, which showed that more 
AcLDL was catabolized in confluent cultures than in sparse 
cultures. 
A different approach was employed to determine high-affinity 
binding, intracellular content and degradation rates. These 
data were obtained by competition experiments in which un-
labelled lipoproteins competed with labelled lipoproteins 
for interaction with the cell surface. In Table 3.7, a 
comparison was drawn between the uptake and degradation of 
LDL and AcLDL by high-affinity receptors. Up-regulated 
sparse cultures metabolize more LDL than do up-regulated 
confluent cultures. In contrast, up-regulated sparse cul-
tures metabolize less AclDL than do confluent cultures. 







































































































































































































































































































































































































































































































































































































































































































































































































































increased metabolism of LDL, whereas the receptor-mediated 
uptake and degradation of AcLDL was not affected by up-
regulation. The maximum number of LDL receptors per cell 
was estimated to be about 98 000, while the maximum number 
of AcLDL receptors per cell was about 31 000 (see Methods 
2.1.5). In comparison, human fibroblasts produce a maximum 
of 20 000 - 50 000 LDL receptors per cell (113) and macro-
phages have about 20 000 - 40 000 receptors per cell for 
AcLDL (78). 
4°C: An alternative approach to measure the k0 values of 
LDL and AcLDL was to incubate cells at 4°c with Hepes-medium 
containing increasing amounts of 125 I-lipoproteins. After 
2 h~ the cells were washed, dissolved in 1 M NaOH and counted. 
This solution was assumed to represent the amount of surface 
bound 125 I-lipoproteins, since at 4°c no internalization of 
the lipoproteins occurs (114) (Figure 3.9). Two-component 
curves were obtained for both 125 I-LDL and 125 I-AcLDL at 
different cell densities and states of receptor regulation. 
The half-maximal values, determined using the Scatchard method 
(see Methods 2. l .5) were about 4-6 µg 1251-AcLDL protein/ml 
in .cells which had not been pre-treated with LPDS-medium for 
48 h~ regardless of cell density (Table 3.8) . In an experi-
ment in which confluent cells had been up-regulated, the 
half-maximal value was 13 µg 125 I-AcLDL protein/ml. There-
fore, these results obtained at 4°C confirm the high-affinity 
of endothelial cell receptors for AcLDL, and are consistent 
in that this affinity was not affected by regulation or with 
FIGURE 3.9: ENDOTHELIAL CELL BINDING OF 125 I-LIPOPROTEINS 
AT 4°C 
Endothelial cells (A 3c1 2 ) were incubated with increasing 
amounts of 125 I-LDL (• 1) and 125 1-AcLDL (1---1) in 2 ml 
of Hepes-medium at 4°C. After 2 h, the medium was discarded 
and the cells were extensively washed. Subsequently, the 
cells were solubilized in l M NaOH overnight at 37°c. Th e 
radioactivity (binding) and the protein contents were then 
determined. 
A. The ce 11 s were not up-regulated and the experiment was 
performed on day 2. 
B. The Ce 11 S were not up-regulated and were used on day 9. 
C. Cells had been up-regulated for 24 h ; n 2 ml of LPDS-
medium. On day 1 2, the cells were used for experiment-
ation. 
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TABLE 3.8: AFFlNITY CONSTANTS, BINDING CAPACITY AND 
RECEPTOR NUMBERS PER CELL. 
Equilibrium dissociation constants (~ ), maximum binding 
capacity (Vmax) and receptor numbers per cell were determined 
from the linearization plots of saturable 
125 I-1ipoprotein 
binding data obtained at 4°c (Figure 3.9). k~ values were 
calculated using the Scatchard analysis method (see Methods 
2.1.5). 
Age of 
ko (µg protein/ml} Experiments culture 
(days) LDL AcLDL 
-· 
1+ 2 3. l 5.6 
2 + 9 20.4 4. l 
3* 1 2 18.5 l 3. 0 
+ Cells had not been up-regulated. 
* Cells had been up-regulated for 24 h in LPDS-medium. 
96 
age. For LDL, the half-maximal binding values at 4°C were 
about 20 µg 125 1-LDL protein/ml in two experiments which are 
consistent with the results obtained at 37°C. However, in 
another experiment the half-maximal binding value was 3. 1 µg 
protein/ml. This result could arise from the relatively 
high non-saturable . component which would tend to mask the 
saturable component and give rise to inaccuracies in obtain-
ing half-maximal values. 
0 0 
In view of the studies on receptor affinity at 37 C and 4 C, 
it can be concluded that temperature has no effect on the 
binding of lipoproteins to the receptors. The k0 values 
obtained for receptor affinity of AcLDL at 37°c (2-5 µg 
protein/ml) and 4°c (4-6 µg protein/ml) were in a similar 
range. The same similarity of k0 values for LDL 
receptor 
affinity at 4°C and 37°C were observed, falling in the range 
of ~bout 20-30 µg protein/ml. In addition to the receptor 
affinity being temperature independent, it was shown that 
the age of the culture does not affect the receptor affinity 
for either LDL or AcLDL. 
3,3.2. Receptor activity with culture age 
Considering the importance of the role of endothelial repair 
after damage to the intact monolayer (see Introduction 1.4), 
it was of relevance to study the receptor activities of these 
cells for LDL and AcLDL in cultures of increasing age. 
The cells were pre•incubated for 48 h in LPPS~medium, 
97 
followed by a 4 h incubation at 37°C in LPDS-medium containing 
125 1-LDL or 125 1-AcLDL in the presence or absence of unlabel~ 
led LDL or AcLDL, respectively. The degradation rates,de-
pendent on high-affinity processes of both 125 1-LDL and 125 1-
AcLDL,~ere measured on the specified days. This parameter 
was corrected for low-affinity non-saturable degradation by 
subtracting the values obtained in the presence of unlabelled 
lipoprotein from those obtained in the absence of unlabelled 
lipoproteins. Degradation rates have been used to illus-
trate · the results obtained. Since the amount of lipoprotein 
bound is the rate limiting step in the degradation pathway, 
the rate of degradation is a reflection of the number of lipo-
protein receptors. Because of the sensitivity and reproduci-
bility of the assay employed to measure the degradation of 
lipoproteins (degradation values of duplicate dishes were 
always within 10 % of each other), this parameter was often 
used in preference to the binding data to investigate recep-
tor activity. This approach avoids the problems encountered 
in obtaining binding data, where the large amounts of non-
saturable lipoproteins bound tended to mask high-affinity 
bound material (see Results 3.3 .1 ) . Sin ce it has been 
found by Goldstein ~t~l (155) that LDL binds in a saturable 
high-affinity manner to glass beads, there is a possibility 
that perhaps the lipoproteins bind to the plastic dishes in 
a similar manner. In addition, the degradation assay avoids 
manipulation and possible loss of cells. The degradation 
rates are also obtained independently of the problems in-
volved in obtaining quantitative releases of bound lipoproteins 
to the cells. 
98 
The pattern that emerged for the degradation rates of 125 I-
AcLDL with increasing days in culture was quite different 
to that obtained for 125 I-LDL (Figure 3.10), Although com-
paratively little 125 I-AcLDL was degraded in sparse cultures, 
the degradation rate increased steadily with increasing age 
of culture. In contrast, the largest amount of 125 I-LDL 
degraded was obtained in sparse cultures~ and this amount 
decreased with increasing culture age, This phenomenon was 
consistently found in two other experiments, with the amount 
of 125 I-AcLDL degraded from day 4 to day 10, increasing by 
344 + 84 % and that of 125 1-LDL, during the same period~ dec-
reasing by 46 + 7% (Table 3,9). At low concentrations (10 -
20 µ9 protein/ml) of the 125 I-lipoproteins, sparse cultures 
degrade more 125 I-LDL than 125 I-AcLDL. In contrast, con-
fluent cultures degrade more 125 I-AcLDL than 125 I ~LDL. 
However, Figure 3.10 does not represent maximum levels of 
degradation since the cells were not exposed to saturating 
concentrations of the lipoproteins. 
The internalization index (obtained by the addition of deg-
radation and intracellula r values divided by the binding 
values) provides a measure of the efficiency or rate of in-
ternalization of bound lipoproteins (156). In sparse and 
confluent up-regulated cell cultures, the internalization 
index for LDL and AcLDL was similar (Table 3. 10), being 
about 26. In addition, the internalization index remains 
the same for both LDL and AcLDL with increasing culture age. 
There is no indication of a decrease in the internalization 











QJ E ,, ""O ,, 
' 0 .... C C 1 , ..... I 
QJ QJ / +- - o ... / 0 "' ...... I '- 0 I 
0. '- , 
0 0. I 
0. / 
O'l d 
I :::i. I ........ I 
If) 





0 4 8 12 16 
days in culture 
FIGURE 3. 10: HIGH AFFINITY DEGRADATION OF 125 1-LIPOPROTEINS 
BY ENDOTHELIAL CELLS AS A FUNCTION OF CULTURE 
AGE 
Endothelial cells (A 3c1 2 ) were up-regulated with 2 ml of LPDS-
medium for 48 h, prior to incubation with 20 µg protein/ml of 
125 I-LDL (• 1) or 125 I-AcLDL (o---o) in the presence or 
absence of 200 µg protein/ml of unlabelled lipoproteins at 
37°c. After 4 h, the medium was removed and precipitated 
with trichloroacetic acid (TCA). The TCA-soluble material 
was analysed for 125 I-lipoprotein degradation products. High 
affinity degradation was determined by the difference between 
the values obtained in the absence and presence of unlabelled 
lipoproteins. 























































































































































































































































































































































































































































































































































































































TABLE 3. 10: INTERNALIZATION INDEX 
Endothelial cells were either up-regulated for 48 h or 
maintained in FCS-medium (i.e. no up-regulation). 
Subsequently, cells were incubated for 4 hat 37°C with 10 µg 
protein/ml of 125 I-lipoprotein in the presence or absence of 
200 µg protein/ml of unlabelled lipoprotein. The medium and 
cells were analysed for the amounts of bound (B), internalized 
(I) and degraded (D) material. Each parameter was corrected 
for the low-affinity component, and high-affinity values 
(shown in Table 3.7) were used to determine the internalization 
index. 
Internalization index (~} 
Treatment Spa rs e cultures Confluent cultures 
AcLDL L DL AcLDL L DL 
up-regulation 23 26 26 28 
no up-regulation 34 23 51 l 2 
102 
results indicate that endothelial cells at confluence do 
internalize and degrade LDL bound to the surface. This is 
in contradiction to Fielding~~ (163) and Vlodavsky et 
al (66), but is in accord with the findings of Coetzee ~ ~ 
(67) (see also Discussion). 
3.3.3. Receptor regulation 
Early work had shown that the receptors for LDL on various 
cell types could be up-regulated (i.e. an increased number 
of surface receptors due to cellular receptor synthesis 
following removal of cholesterol delivery to the cells) and 
down-regulated (i.e. a decreased number of surface receptors 
due to inhibition of receptor synthesis upon delivery of 
excess cholesterol to the cells). Incubation of the cells 
with LPDS-medium is a well-established means of up-regulating 
LDL receptors on cells (145,146). In contrast, the addition 
of medium containing cholesterol derivatives which freely 
traverse the cell membrane, such as 25-hydroxycholesterol, 
have been found to down-regulate the LDL receptors of cells 
(170). 
!!Q_:regulation with LPDS-medium time course: Endothelial 
cells (A 3c1 2 ) were up-regulated by the 
addition of 2 ml of 
LPDS-medium for varying incubation times at 37°c. There-
ft th 11 . b d . h l 
2 5 I 1· ' · a er, e ce s were 1ncu ate w,t - 1poprote1ns for 
4 hand subsequently the amounts bound and internalized and 
the rates of degradation were determined (Figure 3.11). 
In the case of 
125 I-LDL~ both the amount of cell-associated 
FIGURE 3.11; UP-REGULATION TIME COURSE OF ENDOTHELIAL 
CELL RECEPTORS. 
Endothelial cells were up-regulated in 2 ml of LPDS-m~dium 
for the specified time . periods. The medium was changed 
every 24 h. Subsequently on day 6, cells were incubated 
with 10 µg protein/ml of either 125 I-LDL (• •) or 
125 1-AcLDL (o---o) at 37°c. After 4 h, the cells were 
cooled to 4°C, and the medium was collected for determina-
tion of 125 I-1ipoprotein degraded products (see Methods 
2.1.4). The cells were extensively washed and then analysed 
for cell-associated 125 I-1ipoproteins and protein content . 
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and the rate of degradation reached a peak after a 48 h 
incubation with LPDS-medium. The increase in degradation 
rate, from cells which had not been incubated with LPDS-
medium to cells which had had a 48 h incubation with LPDS-
medium, was 9-fold. Upon longer incubation of the cells 
(for 72 h) with LPDS-medium a decrease in receptor activity 
resulted. The reason for this is not clearly understood. 
A possible explanation relates to the long exposure of the 
cells to a depleted growth medium (LPDS-medium) and a 
possible decreased ability of the cells to maintain normal 
functions under these conditions. 
In contrast, an ~p-regulation of the AcLDL receptor was not 
evident. Cells which had been incubated with LPDS-medium 
were compared to those which had not received LPDS-medium 
prior to incubation with 125 I-AcLDL. It was found that 
regardless of the time of incubation with LPDS-medium (up 
to 22 h), the amounts of cell-associated and degraded 
material remained relatively unchanged. In a number of 
simila r experiments (Table 3.11) no significant up-regulation 
was observed as a result of a 48 h exposure to LPDS-medium. 
Down-regulation wjth 25-hydroxycholesterol time course: 
Endothelial cells were incubated with LPDS-medium containing 
25-hydroxycholesterol for increasing periods of incubation. 
The decrease in the receptors was determined by subsequently 
incubating the cells with 125 1-lipoproteins and determining 































































































































































































































































































































































































































































































































































































































































































































TABLE 3. 12: DOWN-REGULATION TIME COURSE OF THE LIPOPROTEIN 
RECEPTORS 
Endothelial cells (A 3c1 2) were incubated for
 the specified 
ti mes w i th 2 0 µ g / m 1 of 2 5 - h y d r o xy ch o 1 es t er o 1 i n 2 m 1 of LP D s-
medium. The remaining cells were maintained in FCS-medium. 
On day 9, the cells were incubated with 10 µg protein/ml of 
125 I-lipoproteins at 37°c for 4 h. Degradation values were 
obtained as described in Methods 2.1.4. 
of duplicate values. 
Time 







Degradation of 125 I-lipoproteins 
(ng protein/mg cell protein) 
























in receptors of both LDL and AcLDL occurs. However, the 
down-regulation of the LDL receptor was far more rapid. 
Within the first 12 h, the LDL receptor was down-regulated 
by more than 90%, while the regulation of the AcLDL receptor 
was not affected during this short exposure to 25-hydroxy-
cholesterol. Even after 24 h, the receptor for AcLDL was 
down-regulated by only 20%. Although in this experiment 
the cells looked viable even after a 48 h exposure to 25-
hydroxycholesterol, on another occasion cell death had occur-
red shortly after 24 h. Thus, in subsequent experiments, 
cells were incubated for only 24 h with 25-hydroxycholesterol. 
Similar findings on down-regulation were found in a number 
of different experiments (Table 3. 13). The receptor activity 
for LDL was down-regulated by about 96% as a result of a 24 h 
exposure to 25-hydroxycholesterol,while that for AcLDL was 
down-regulated by about 30% during the same period. Whether 
25-hydroxycholesterol is causing a down-regulation of recep-
tors or whether its toxic effect is somehow interfering with 
the uptake and degradation of 125 I-lipoproteins, was a matter 
to consider. A more reliable method to down-regulate the 
receptors was by incubating the cells with LPDS-medium con-
taining either LDL or AcLDL (see Table 3.14). 
Initially the up- and down-regulation of the receptor acti-
vities for LDL and AcLDL were determined using the total 
degradation rates. Since the degradation of receptor-
mediated lipoproteins consistently made up 85-98% of the 






































































































































































































































































































































































































































































































































































































other experiments (see Table 3.14), high-affinity degrada-
tion rates were determined leading to the same conclusions 
regarding the regulation of the two receptors. 
Effect of culture age on up- and down-regulation: It has 
so far been established that the LDL receptor was susceptible 
to up- and down-regulation (Figure 3.11 and Table 3. 12). 
However, although the AcLDL receptor was not susceptible to 
up-regulation by LPDS-medium {Figure 3. 11), about a 30% down-
regulation of the AcLDL receptor occurred upon expsure to 
25-hydroxycholesterol (Table 3. 13). Furthermore, it has 
been established that culture age (Table 3. 14) has no effect 
on the regulation of receptors, except perhaps in the case 
of AcLDL regulation of the LDL receptor. 
When the down-regulated state of the LDL receptor {obtained 
by incubation of the cells with LPDS-medium + LDL) was com-
pared to the up-regulated state (the cells were exposed to 
LPDS-medium only), there was an 82% increase in receptor 
activity in sparse cultures. Under the same conditions, 
using confluent cultures, the increase in receptor activity 
was 80 %. Thus there appears to be no culture age effect 
on the regulation of the LDL receptor if the down-regulated 
state of receptors is obtained by exposing the cells to 
LPDS-medium containing LDL. 
A new finding was obtained in that the LDL receptor could 
be regulated by exposing the cells to AcLDL. In this case 
TABLE 3. 14: 
11 0 
EFFECT OF CULTURE AGE ON UP- AND DOWN-REGULATION 
OF BOTH SPARSE AND CONFLUENT CULTURES 
Endothelial cells,of both sparse and confluent cultures were 
treated for 48 h with 2 ml of either FCS-medium, LPDS-medium, 
LPDS-medium containing either 100 µg protein/ml of LDL or 
AcLDL or for 24 h with LPDS-medium containing 20 µg/ml of 
25-hydroxycholesterol (25-0H-C). The various incubation 
media were changed every 24 h . The cells were then washed 
twice with phosphate buffered saline. Subsequently they 
were incubated with 20 µg protein/ml of 
125 I-lipoproteins in 
the presence or absence of 200 µg protein/ml of unlabelled 
lipoproteins The amount of 125 I-lipoprotein degraded was 
determined and corrected for non-saturable material. These 
two experiments were carried out independently, using different 
cell cultures. Data are the mean of duplicate dishes. 
High - a ff in i ty degradation 
Ce 11 Treatment of125 I-lipoproteins 
cultures (nq orotein/mq cell protein) 
LDL AcL DL 
Sparse L PDS-medium 1 061 711 
(day 4) L PDS-medium + L DL 19 4 1031 
L PDS-medium + AcLDL 477 604 
L PDS-medium + 25-0H-C 57 621 
F CS-medium 309 751 
Confluent L PDS-medium 643 1029 
( day 9) L PDS-medium + L DL 131 1184 
L PDS-medium + AcLDL 79 927 
L PDS-medium + 25-0H-C 8 688 
F CS-medium 85 1029 
1 
l l l 
a difference in the extent of receptor regulation between 
sparse and confluent cultures was observed. When the LDL 
receptor was down-regulated by exposure to LPDS-medium con-
taining AcLDL, an increase in receptor activity of 55% 
occurred in sparse cultures when the cells were incubated 
with LPDS-medium only. However, under the same conditions, 
using confluent cultures, the receptor activity increased 
by 88%. This increase in LDL receptor activity with cul-
ture age could possibly be related to the increased catab-
olism of AcLDL by confluent cells (see Results 3.3.2). 
In the case of the AcLDL receptor, the increase in receptor 
activity between cells incubated with LPDS-medium containing 
AcLDL to those incubated with LPDS-medium only, was 15 % for 
sparse cultures. Confluent cultures under th~ same condi-
tions e xh ibited a 10% increase in receptor activity. In 
contrast to the ability of the LDL receptor being regulated 
by AcLDL, the AcLDL receptor was not regulated by LDL under 
si mila r circumstances, in either sparse or confluent cul-
tures. 
Using cells incubated with LPOS-medium only as a measure of 
maximal LDL receptor activity, the down-regulation of the 
LDL receptor by 25-hydroxycholesterol was greater than by 
LPDS-medium containing LDL (i.e. 95 % in sparse cultures and 
99 % in confluent cultures). By comparison, the down-
regulation of the AcLDL receptor by 25-hydroxycholesterol 
was 13% in sparse cultures and 33% in confluent cultures. 
112 
This regulation of the AcLDL receptor is thus relatively 
small when compared to the regulation of the LDL receptor. 
3.3.4. Receptor competition studies 
From the data obtained concerning receptor regulation {see 
Results 3.3.3) and receptor activity with culture age {see 
Results 3.3.2), it was suggested that endothelial cells had 
two distinct receptors for LDL and AcLDL. This was estab-
lished by incubating the cells with 125 1-AcLDL in the 
presence of increasing amounts of either unlabelled AcLDL 
or unlabelled LDL. Alternatively, cells were incubated 
with 125 1-LDL in the presence of increasing amounts of 
either unlabelled LDL or unlabelled AcLDL. The results of 
the competition experiments shown in Figure 3. 12 indicate 
that whereas unlabelled AcLDL competed effectively with 
125 1-AcLDL, unlabelled LDL did not compete, even after an 
addition of 300 µg protein/ml. Conversely, unlabelled 
AcLDL did not compete with 125 I-LDL, but unlabelled LDL did. 
In comparing Figure 3.12A to Figure 3.128, it can be seen 
that the affinity of endothelial receptors for AcLDL was 
greater than the affinity of receptors for LDL. Addition 
of 50 µg protein/ml of unlabelled AcLDL resulted in a 73% 
competition with 125 I-AcLDL, while 50 µ9 protein/ml -of un-
labelled LDL resulted in only a 35 % competition with 125 1-
LDL. These results are consistent with those found in 
Results 3.3. 1, where the half-~aximal values for AcLDL were 
lower than those for LDL in experiments performed at 37°c. 
FIGURE 3. l 2: COMPETITION STUDIES OF LIPOPROTEIN RECEPTORS 
IN ENDOTHELIAL CELLS 
Endothelial cells were up-regulated for 24 h with 2 ml of 
LPDS-medium. 
A. On day 5, cells were incubated with 2 ml of LPDS-medium 
containing 5 µg protein/ml of 125 I-LDL in the presence 
of the increasing specified amounts of unlabelled LDL 
(••~~•) or unlabelled AcLDL (o--~o). 
B. On day 5, cells were incubated with 2 ml of LPDS-medium 
containing 5 µg protein/ml of 125 I-AcLDL in the presence 
of the increasing specified amounts of unlabelled AcLDL 
(o---o) or unlabelled LDL (-•~-•). 
The amounts of 125 I-lipoproteins were measured as a function 
of increasing concentrations of unlabelled lipoproteins. 
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From the above results it was concluded that two distinct 
receptors exist on endothelial cells for LDL and AcLDL, and 
that these receptors had different affinities for their 
respective lipoprotein. 
3.4. INHIBITORS OF LYSOSOMAL FUNCTION 
Since the degradation of LDL is known to occur via the lyso-
somes in a variety of cell types, the dependence of the 
degradation of AcLDL was also investigated. This was done 
b . b . 11 ·th 125 1 1 · t . . th y 1ncu at,ng ce s w, - 1popro e1ns ,n e presence 
or absence of lysosomal inhibitors. The twoinhibitors used 
were chloroquine and leupeptin. Chloroquine is a weak base 
which accumulates inside the fysosomes by being trapped within 
the organelles by protonation (157). This reduces the pH 
and hence the hydrolytic activities of the acidic lysosomes. 
Chloroquine also directly inhibits cathepsin B (158). 
Leupeptin, a modified tetrapeptide, isolated from actino-
mycetes (159) acts against thiol proteinases such as the 
cathepsins B, H and L. Cells (A 3c1 2 ) were incubated for 
4 hat 37°c with 125 1-lipoproteins in the presence or absence 
of chloroquine or leupeptin, and the degradation rates of 
the 125 I-lipoproteins were measured (Table 3. 15). The degra-
dation rate of 125 I-LDL was inhibited 86~99% by chloroquine 
and 23-52% by leupeptin. Similarly, 
125 1-AcLDL degradation 
was inhibited 90-98% by chloroquine and 8-24% by leupeptin. 






























































































































































































































































































































































































































































































































































































































degradation occurs via the lysosomes. Chloroquine was a 
much more powerful inhibitory agent, possibly due to its 
basic property which could perhaps inactivate the majority 
of the enzymes involved in lipoprotein degradation. 
3.5. COMPARISON TO OTHER CELL TYPES 
The amounts of LDL and AcLDL that were cell-associated and 
degraded in confluent endothelial cells (A 3c1 2) were compared 
to the amounts processed by macrophages (J 774) and human 
skin fibroblasts (GM 0203 and SB) . 
All the cells were incubated with either 125 I-LDL or 125 I-
AcLDL.( Table 3.16). When endothelial cells were compared 
to fibroblasts, the amout of cell-associated and degraded 
125 I-LDL was found to be about 10-fold higher in fibroblasts 
after a 4 h incubation period. On the other hand, the 
amount of cell-associated 125 I-AcLDL in endothelial cells was 
about 3-6 times greater than that obtained with fibroblasts. 
In addition, the amount of 125 I-AcLDL degra ded by endothelial 
cells was considerably more than that degraded by fibroblasts. 
In fact, the amount of 125 I-AcLDL degraded by fibroblasts 
was only 1-3 % by comparison, even after a 24 h incubation 
period. 
Macrophages, like endothelial cells, degraded far more 






































































































































































































































































































































































































































































































































































































































































































amount of cell-associated and degraded 
125 I-LDL by macro-
phages was greater than that by endothelial cells, the 
amounts remained considerably lower than those obtained using 
fibroblasts, after either a 4 h or 24 h incubation period. 
In macrophages, the amount of cell-associated 
125 1-AcLDL was 
greater than that associated with endothelial cells after a 
4 h incubation period, but less after a 24 h incubation period. 
125 
This same pattern applied to the degraded I-AcLDL, where, 
after a 4 h incubation period, macrophages degraded almost 
twice the amount of 125 1-AcLDL degraded by endothelial cells. 
Yet after a 24 h incubation period, both endothelial cells and 
macrophages degraded similar amounts of 
125 1-AcLDL. This non-
linearity in the degradation of AcLDL by macrophages could 
possibly be explained if the added substrate had been depleted. 
However, upon calculation of the amount added to that degraded, 
this was not the case. The other possibility could have been 
that the cells were not favourably disposed to such a long 
incubation period with 125 1-lipoproteins. However, the catab-
olism of LDL by macrophages was linear from 4 h to 24 h, im-
plying that the cells were not affected adversely by the long 
. b t· ·th 125 1 l. t . 1ncu a 10n w1 - 1popro e1ns. In addition, the appear-
ance of the cells had remained unchanged during the 24 h. 
Therefore, it seems that there is no clear answer to clarify 
this phenomenon. 
From the above results it could be concluded that while 
fibroblasts catabolize LDL in far greater quantities than 
either macrophages or endothelial cells, the catabolism of 
1 1 9 
AcLDL by fibroblasts is negligible. In contrast, macro-
phages and endothelial cells have receptors which can bind 
large quantities of AcLDL, as well as receptors which recog-
nize LDL. The activities of the two different receptors 
are modulated according to age of cells in culture. 
3.6. CHOLESTEROL METABOLISM 
3.6. 1. Determination of ACAT activity 
Sinte LDL is able to stimulate the incorporation of 
14 c-
oleic acid into cholesteryl oleate in fibroblasts (160), the 
ability of both LDL and AcLDL to cause the same effect in 
endothelial cells was investigated. To control for varia-
tions in the esterification capacity of different cell 
types, the acyl-CoA cholesterol acyltransferase (ACAT) 
activities, induced by either LDL or AcLDL, were compared to 
those induced by 25-hydroxycholesterol. The effect of the 
latter does not depend on receptor number. 
In order to measure the LDL induction of ACAT activity, the 
cells were up-regulated for 48 h in LPDS-medium (Table 3. 17). 
In both confluent (Expt. 1) and sparse (Expt. 2) cultures, 
the ACAT activity was induced by LDL. The relative amount 
of LDL induction of ACAT was less in confluent cultures than 
in sparse cultures. This was not unexpected, since, as 
previously shown (Table 3.7), LDL receptor activity decreased 













































































































































































































































































































































































































































































































































































































































































































































































































1 2 1 
in confluent cultures is rather significant, since it has 
been shown that ACAT activity is regulated only by receptor-
mediated LDL and not by adsorptive endocytosis (9). Thus, 
this is a further contradiction to the studies by Fielding 
~ ~ (163) and Vlodavsky ~ ~ (66), in that confluent 
cultures do in fact bind, internalize and degrade LDL. The 
observations by these authors that confluent endothelial 
cells only bind, but do not internalize or degrade LDL is 
incompatible with these results. 
The measurement of ACAT inducibility by AcLDL was obtained 
under the same conditions as for LDL. It was found that 
in up-regulated confluent {Expt. 1) and sparse (Expt. 2) 
cultures, AcLDL was indeed able to induce ACAT activity. 
The relative induction of ACAT was greater in confluent 
cultures than in sparse cultures. This is again consistent 
with the results obtained of AcLDL receptor activity (Table 
3.7), which increased with age of culture. 
3.6.2. Determination of cellular cholesterol 
AcLDL and MDA-LDL (another negatively-modified LDL) have 
been shown to cause a massive accumulation of cholesteryl 
esters in macrophages (76,77,78, 133). In addition, it had 
been shown by Stein and Stein (84) that incubation of endo-
thelial cells with AcLDL caused an increase from 5.7 + 1.4 
in control cells to 14.6 ~ 2.6 µg cholesteryl ester/mg cell 
protein. These results were difficult to interpret since 
details of the experiment were not given. Whether AcLDL 
122 
would cause a similar effect in the A3c1 2 strain of bovine 
aortic endothelial cells was investigated • . 
Endothelial cells (A 3c1 2) and macrophages (J 774) were in-
cubated with AcLDL, and the amount of cellular cholesterol 
in both cell types was determined. In the case of macro-
phages the increase in total cellular cholesterol was in the 
form of cholesteryl esters, while in endothelial cells the 
increase was in the form of free cholesterol. In Expt. 1 
and Expt. 2 (Table 3. 18) endothelial cells were incubated 
with 25 µg protein/ml of AcLDL or LDL for 72 h with medium 
changes every 24 h. LDL and AcLDL were added to LPDS-
medium in Expt. l and to FCS-medium in Expt. 2. After in-
cubation with the lipoproteins, the cells were harvested and 
the amounts of cellular cholesterol determined using a fluori-
metric enzymatic assay (see Methods 2.1.8). 
In confluent cultures, cells which had been exposed to LPDS-
medium had considerably less cholesterol than those which 
had been exposed to FCS-medium. This would explain why the 
increase in total cholesterol in cells exposed to LDL in Expt. 
1 (LPDS-medium) was almost double that in Expt. 2 (FCS-medium). 
However, the increase in total cholesterol upon exposure of 
the cells to AcLDL was similar in both cases. This was not 
unexpected as the AcLDL receptor has been found not to be very 
susceptible to regulation. 
In Expt. 1 and Expt. 2, the increase in free cholesterol was 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































compared to those cells exposed to medium alone. For example, 
in sparse endothelial cultures, the amount of free cholesterol 
increased by about 14 µg/mg cell protein, from 42 to 56 µg/mg 
cell protein when cells were incubated with FCS-medium in the 
presence of AcLDL. In contrast, the addition of LDL to the 
cells under the same conditions resulted in only about a 1.5 
µg/mg cell protein increase. In confluent cultures, the in-
crease of free cholesterol upon addition of AcLDL to the cells 
was slightly more than in sparse cultures. Similarly, the 
addition of LDL to confluent cultures resulted in a greater 
amount of free cholesterol than in sparse cultures. In the 
confluent cultures in which LPDS-medium had been supplemented 
with LDL, the increase in free cholesterol was about 17 µg/mg 
cell protein from about 20 to 37 µg/mg cell protein, while 
those ex posed to AcLDL under the same conditions resulted in 
an i ncrease of free cholesterol of about 23 µg/mg cell 
protein. The addition of 125 µg protein/ml of AcLDL to the 
cells did not result in a further increase of cholesterol. 
In t hese endothelial cells, the increase in total cellular 
choles t e r ol was due to the increase of free cholesterol, while 
only a very small proportion existed as cholesteryl esters. 
The va r iation between duplicate cholesterol determinations 
were always less than 5%. Since the accuracy of the choles-
teryl ester determination is dependent on the ratio of free 
cholesterol to cholesteryl ester, the limit of sensitivity 
of the cholesteryl ester determination was estimated to be 
less than 10 % of the free cholesterol value. The cholesteryl 
ester content in endothelial cells exposed to AcLDL was less 
than 3 µg/mg cell protein, and that of cells exposed to LDL 
125 
was about 4 µg/mg cell protein. 
Since it had been previously demonstrated that chloroquine 
inhibited LDL and AcLDL degradation (see Results 3.4), chloro-
quine was added to the medium containing either LDL or AcLDL, 
to investigate whether a further increase in cholesterol 
would occur. The increase in total cholesterol was far more 
marked with AcLDL (about 10-15 µg/mg cell protein) than LDL 
(about 4 µg/mg cell protein). However, the increase in 
total cholesterol was mainly due to free cholesterol. 
On the other hand, macrophages incubated with AcLDL for 48 h 
resulted in more than twice the amount of total cholesterol 
obtained in macrophages exposed to FCS-medium alone (i.e. 
from 39-95 µg/mg cell protein). In this case, the amount 
of free cholesterol did not increase, and most of the choles-
terol was detected as cholesteryl esters. Upon addition of 
chloroquine to the cells incubating with AcLDL, the total 
cellular cholesterol further increased to 126 µg/mg cell 
protein, and although the amount of free cholesterol in-
creased by 13 µg/mg cel l protein, the bulk of the cholesterol 
in the cells existed as cholesteryl esters {73 µg/mg cell 
protein). 
In summary, it has been observed that AcLDL causes a greater 
cholesterol increase in endothelial cells, than does LDL. 
However, considering the rate of uptake of AcLDL by endo-
thelial cells, the limited accumulation of cholesterol in 
126 
these cells is not incompatible with the AcLDL uptake data. 
For example, in confluent endothelial cells, the expected 
amount of cholesterol uptake via AclDL in 72 his approxi-
mately 32 µg/mg cell protein, assuming an internalization 
rate for AcLDL of 4 µg/mg protein/h (Figure 3.8). This 
phenomenon in endothelial cells is different to that in 
macrophages, where incubation with AcLDL results in a rela-
tively large increase in total cholesterol content. Further-
more, the bulk of the increase in total cholesterol exists as 
cholesteryl esters, whereas in endothelial cells the choles-
terol increase is due to the increase in free cholesterol. 
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4. DISCUSSION 
Before analysing the results obtained in this manuscript, 
it is of relevance to examine the cell system employed, in 
the light of the different conditions under which endo-
thelial cells have been maintained in vitro. The saturation 
cell density obtained in a confluent monolayer of bovine 
aortic endothelial cells (A 3c1 2 ) grown on gelatin-coated 
Petri dishes was 0.64 x 105 cells/cm2 • This was consistent 
with the saturation cell density obtained by Gospodarowicz 
et~ (38), which was 0.56 x 10 5 cells/cm2 . On the other 
hand, Schwartz (19), Duthu and Smith (41) and Davies (40) 
have shown endothelial cells to grow to a saturation cell 
density of 1.5 x 10 5 cells/cm2 . The bovine aortic endo-
thelial cells used by Gospodarowicz ~ ~ (38) were isolated 
i n a si milar way to the cells obtained in this study, i.e. 
by mech anical scraping of the surface of the lumen. In 
addition, these cells were isolated and maintained in the 
presence of 100 ng/ml of fibroblast growth factor (FGF), 
resulting in a confluent monolayer of cells for a long period 
of time, with no evidence of 11 sprouters 11 • According to 
these authors, upon removal of FGF, the cells continue their 
growth in a similar way to cells continually exposed to FGF. 
In contrast, Duthu and Smith {41), Schwartz (19) and Davies 
(40) prepared bovine aortic endothelial cells by dissociation 
of the intima with collagenase. Duthu and Smith (41), after 
isolation of the cells, maintained them in the presence of 
FGF. However, upon removal of FGF, the cells no longer 
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maintained a confluent monolayer and formed a multilayer. 
Schwartz (19) obtained cells by either a 3H-thymidine selec-
tion or cloning. In both cases, the cells formed a cobble-
stone mono l ayer of s ma 11 , round c el l s , w hi ·ch co u l d be ma i n -
tained in the absence of FGF. However, this monolayer 
eventually gave rise to "sprouters". Although the cells 
used in this study, when grown on gelatin-coated dishes, 
visually behave in a similar manner to those obtained by 
Schwartz {19), the saturation cell density was closer to 
that obtained by Gospodarowicz ~ ~ (38) . Hence, there 
appears to be some variation in the morphology and growth 
characteristics of cultured bovine aortic endothelial cells, 
which in turn could possibly affect certain functional aspects 
of the cells. It should also be borne in mind that such 
cells grovrn ~ vitro need not reflect the true~ vivo endo-
thelial layer, although they do continue to provide a con-
venie nt model system for studies, which can form a basis for 
future in vivo studies. 
A number of studies has previously identified a pathway in 
several different cell types by which low density lipoproteins 
{LDL) are taken up into the cells via a saturable, high-
affinity receptor. Most of the studies reported have been 
carried out with cultured fibroblasts (8,9) and smooth muscle 
cells (115,116), and more recently with endothelial cells 
(21,28,66, 135). After internalization, the lipoprotein apo-
protein is degraded in the lysosomes to amino acids and the 
cholesteryl ester component is hydrolysed by a lysosomal 
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cholesterol esterase to free cholesterol, which can be re-
esterified by the enzyme, acyl-CoA: cholesterol acyl trans-
ferase. This LDL pathway has been found to regulate the 
uptake, storage and synthesis of cholesterol and thus protect 
cells from an over-accumulation of sterols (9}. In this 
study, the LDL receptor affinity for LDL in bovine aortic 
endothelial cells (A 3c1 2 }, as measured from degradation data, 
was found to correspond to a k0 value of about
 20 µg protein/ 
ml. This equilibrium dissociation constant value in bovine 
aortic endothelial cells was similar to the value obtained 
for endothelial cells from foetal bovine heart, which had 
been reported as 15 µg protein/ml (66), but was considerably 
higher than that found in rabbit arterial endothelial cells, 
where the receptor for LDL reached saturation at 5 µ9 protein/ 
ml (135). 
In addition, it was shown in this study that bovine aortic 
endothelial cells could catabolize AcLDL via a saturable high-
affinity receptor. In the acetylation reaction, acetyl 
groups are attached to the lysine residues of LDL, neutralizing 
the positive charges and increasing the net negative charge 
of the protein. The ability to catabolize negatively-modified 
LDL is not shared by the majority of cultured cell types, such 
as fibroblasts, smooth muscle cells, lymphocytes or adrenal 
cells (78}. However, a high-affinity receptor which recognizes 
negatively-modified LDL has been identified in mouse peritoneal 
macrophages (78,.127,161} and in human monocyte-derived macro-
phages (76,77,133}. The receptor affinity for AcLDL in 
bovine aortic endothelial cells was found to correspond to a 
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kc value of about 2 µg protein/ml, which was considerably 
greater than the receptor affinity for LDL. Stein and Stein 
(84), also using bovine aortic endothelial cells, reported 
that the degradation rates of AcLDL showed evidence of satu-
ration at 10-20 µg protein/ml. By comparison, the macro-
phage AcLDL receptor on mouse peritoneal cells · exhibited a 
half-maximal value of about 10-25 µ9 protein/ml (78,127,161). 
This receptor was found to be the same as that for MDA-LDL 
(78), and the degradation rates of these two negatively-
modified LDLis were found to be similar. The receptor for 
MDA-LDL on human monocyte-derived macrophages had a half-
maximal value of about 5 µ9 protein/ml (76). An interesting 
observation in these two types of macrophages is that, although 
mouse macrophages do not take up and degrade native LDL by a 
high-affinity receptor (127), human macrophages were shown to 
possess LDL receptors which exhibited a kc value for LDL of 
10-25 µg protein/ml (77,162). Therefore, it appears that in 
hu man macrophages, as in bovine aortic endothelial cells, the 
recepto r affinity for negatively-modified LDL is greater than 
that for LDL. Furthermore, these receptor affinities for 
LDL and AcLDL in endothelial cells were temperature-independent. 
This is contrary to the receptor affinity for LDL in human skin 
fibroblasts, where the receptor affinity at 4°c is about twice 
that at 37°C (114). 
One of the problems in this study was the very large low-
affinity (and non-saturable) binding of AcLDL to the endo-
thelial cells, which complicated the experimental processing 
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of results. The approach often used, therefore, was to 
employ degradation data as a measure of receptor activity. 
In the case of LDL, the ~mount of non-saturable material was 
similar for binding, internalization and degradation. This 
implies that non-receptor bound LDL was internalized and 
degraded as effectively as receptor-bound material. However, 
in the case of AcLDL, there was a relatively large amount of 
non-receptor-bound material, compared to receptor-bound 
material. However, the material that was internalized and 
degraded was evidently taken up by the cells to a very large 
extent via receptors. Stein and Stein (90) have presented 
evidence for arterial transendothelial transport of plasma 
low-density lipoproteins via pinocytosis. More recently, 
Leake and Bowyer (164) have studied rates of pinocytosis by 
arterial endothelial cells, and concluded that a major func-
tion of vascular endothelial cells is to transfer substances 
between the plasma and interstitial fluid by diacytosis. 
Diacytosis is the transport process of intact substances, 
such as plasma lipoproteins, involving pinocytosis at one 
surface of the cell, followed by the movement of the pinosome 
to the opposite surface of the cell, and the exocytosis would 
probably become operational for LDL transport once the surface 
receptors are saturated. Since there is no obvious reason 
why this transport system should exclude the transport of 
AcLDL, it could be possible that a large fraction of the non-
receptor-bound material is actually transported by this 
pathway. Since degradation of material transported by 
diacytosis is not expected, the assay used for analysis of 
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degradation products in the medium would not be able to 
detect any intact lipoprotein which had been transported by 
diacytosis. The reason why intracellular material is not 
detected may depend on the level of flux of the vesicles 
through the cell. Also, cells in culture may not exhibit 
diacytosis. However, the high level of non-receptor binding 
may reflect the situation .:!1!. vivo, and thereby contribute to 
an absorptive endocytotic process. Since endothelial cells 
see the full complement of the plasma and thus, presumably, 
a higher concentration of lipoproteins than that present in 
the interstitial fluid, the large non-receptor binding com-
ponent may play a more significant role than that in sub-
endothelial cells. 
A new finding was that cultured bovine aortic endothelial 
cells possess distinct receptors for LDL and AcLDL, of which 
the AcLDL receptors exhibit a higher affinity for their 
respective lipoprotein. The receptors for AcLDL did not 
recognize LDL, and conversely the receptors for LDL did not 
recognize AcLDL. Recently, the isolation of the AcLDL recep-
tor from membranes of murine macrophage line P338D.l was 
reported (134). Furthermore, it was observed that the incu-
bation of the cells with either AcLDL or LDL caused the down-
regulation of the LDL receptor, but neither the addition of 
LDL nor AcLDL down-regulated the AcLDL receptor. This 
phenomenon, whereby only LDL receptors were subject to 
regulation, was also reported for human monocyte-derived 
macrophages (135). Both LDL and MDA-LDL failed to down-
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regulate the MDA-LDL receptor in these cells. The inability 
of the AcLDL receptor to respond to regulation could be an 
explanation for the eventual loading of the macrophages with 
cholesterol to form foam cells and atherosclerotic plaques. 
Down-regulation of the LDL receptor was observed in both 
sparse and confluent cells. This contradicts the findings 
of Vlodavsky ~ ~ (66) that only LDL receptors of sparse 
endothelial cell cultures are susceptible to down-regulation. 
The relationship between LDL receptor activity in endothelial 
cells and cell density has been a matter of controversy for 
some time. Gospodarowicz and co-workers (21 ,28,66,163) have 
consistently reported that confluent, contact-inhibited endo-
thelial cell monolayers bind, but do not internalize or 
degrade LDL. The block in lipoprotein protein uptake extends 
to the cholesterol uptake, thus preventing regulatory effects 
of LDL on cholesterol metabolism (163). By incubating con-
fluent, contact-inhibited endothelial cells with cationized 
LDL, these authors observed that the cells were able to 
degrade the lipoprotein and exhibit the expected regulation 
of the activities of the enzymes required for sterol synthesis 
from acetate and the conversion of cholesterol to cholesteryl 
esters. From these studies, they concluded that the primary 
regulation of LDL catabolism in confluent, contact-inhibited 
cells was the inhibition of uptake of LDL as a result of the 
cell-cell contact (66). In sparse cultures, however, the 
uptake of LDL is primarily via the down-regulation of the 
receptor number. In contrast, Coetzee ~ 2-l {67) have shown 
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that while endothelial cell receptor activity decreases with 
increasing cell density, confluent cultures nevertheless 
take up and degrade significant amounts of LDL. In agreement 
with these results are the findings reported here that in a 
confluent monolayer of cells, a significant amount of LDL was 
bound, internalized and degraded, although at a lower rate 
than in sparse cultures. Furthermore, the efficiency with 
which bound LDL is internalized (as indicated by the interna-
lization index) remained unchanged for sparse and confluent 
cultures (see Results 3.3.2). This implies that the decrease 
in internalization and degradation was to a large extent, or 
completely, due to the observed decrease in cell surface 
recepto r s. This decrease was observed with increasing cell 
density. A factor that could give rise to these contradict-
ing results is the different methods used in obtaining and 
cu lturi ng endothelial cells. Although the cells used in this 
study appear as a confluent monolayer, the fact that the mono-
1 ayer even tu a l l y g a v e r i s e to II s pro u t er s II co u 1 d i mp l y that 
t he monolay er was perhaps not completely contact-inhibited, 
or that the measured amount of internalized and degraded 
material was due to the 11 sprouting 11 • The latter possibility, 
however, appears unlikely, as cells were used at confluence 
before the development of 11 sprouters 11 • The possibility exists 
that the cells might have appeared confluent, but were not 
completely contact-inhibited. However, given the similarity 
between cell densities obtained in confluent cultures used in 
this study and those reported by Gospodarowicz ~ ~ (38), 
and the morphological appearance of the two cell cultures, at 
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least partial confluence in the present cultures used here 
is suggested. It would therefore be expected that a block 
in endocytosis would be evident even in cultures not absolute-
ly confluent or contact-inhibited. However, there ~as no 
indication of any such change as observed above, i.e. no 
change in the internalization index from sparse to confluent 
cultures. This is consistent with the studies of Coetzee 
~ ~ (67), who reported that confluent cultures degrade sig-
nificant amounts of LDL. These authors had used endothelial 
cells which had been a gift from Dr D. Gospodarowicz. The 
cells were foetal bovine heart endothelial cells, isolated 
and maintained in the presence of fibroblast growth factor 
(FGF). It was these cells, too, which had been used to look 
at the LDL receptor in confluent, contact-inhibited cells by 
Vlodavs ky et~ (66). It would be unusual for these cells 
to cha nge in functional characteristics from one laboratory 
to another, when maintained under similar conditions. This 
thus leaves one with equivocal results, which cannot easily 
be explained. 
The number of receptors for AcLDL also changed with cell den-
sity. In comparing the receptor activity of AcLDL to that 
of LDL, whereas the receptor activity of LDL decreased with 
confluence, that of AcLDL increased steadily with increasing 
age of culture. This latter phenomenon was also observed 
in human monocyte-derived macrophages (133), with the MDA~LDL 
receptor being fully expressed only in the second week of 
growth in culture. It would therefore appear that in confluent, 
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monolayered cultures, endothelial cells, to a large extent, 
shut down the mechanism of LDL uptake, thus protecting 
against an over-accumulation of cholesterol. Thus it is 
contradictory to this protection mechanism that confluent 
cells preferentially take up negatively-modified LDL. AcLDL 
has been shown to be recognized by the same receptor that 
binds negatively-modified LDL, namely MDA-LDL (78), which 
can be produced~ vivo. This provides evidence indicating 
that it is possible to have negatively-modified LDL circula-
ting in the bloodstream which can be taken up and degraded 
by endothelial cells as well as by macrophages. 
Another question which arises is the possibiliey of injury to 
other areas by such a modified lipoprotein found in the cir-
culatory system. Although it has been postulated that LDL 
can lead to injury of the endothelium (13), it has y,et to be 
investigated whether negatively-modified LDL would have a 
similar effect. It is rather interesting that, although it 
was shown that AcLDL had hardly any (10-15% down-regulation) 
regulatory effect on the AcLDL receptor, it could regulate 
the LDL receptor, as well as induce the enzyme, acyl-CoA : 
cholesterol acyl transferase (ACAT) into esterifying choles-
terol to cholesteryl esters. An area which needs further 
investigation is the possible regulatory effect of AcLDL on 
the synthesis of cholesterol, i.e. regulation of 3-hydroxy-
3-methylglutaryl coenzyme A reductase. It is possible that 
the 10-15 % down-regulation of the AcLDL receptor by AcLDL may 
not represent the maximum down-regulation of this receptor. 
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This would be the case if the receptor for AcLDL had a 
longer half-life. It has been assumed that the half-life 
of the AcLDL receptor did not differ from that of the LDL 
receptor which is about 16-20 h. However, an experiment 
employing cycloheximide would be able to clarify this point. 
In the atherosclerotic plaques, the cells which have been 
identified as being laden with cholesterol were macrophages 
and smooth muscle cells (10), and not endothelial cells. 
However, Stein and Stein (84) reported an increase in choles-
teryl esters of about 9 µg/mg cell protein in endothelial 
cells upon incubation with AcLDL. In this study it was 
found that incubation of endothelial cells with AclDL caused 
a larger increase in free cholesterol than did LDL, but the 
cholesteryl ester content remained relatively small {<3 to 
6 µg/mg cell prot~in). 
In the one experiment, macrophages were used for comparison, 
and in these cells there was a large accumulation of choles-
teryl esters (57 µg/mg cell protein), which coincided with 
reports by Fogelman and coworkers (76,77, 133) and Goldstein, 
Brown and coworkers (78,127,161). 
On looking at the receptor-mediated pathway of AcLDL, it does 
not appear to differ considerably from the LDL receptor-
mediated pathway. In this study, endothelial cells incubated 
with LDL or AcLDL reached a steady-state of lipoprotein bind-
ing and internalization at about 2 h, with an initial lag of 
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30 min before degradation products were formed. After in-
ternalization, both lipoproteins were delivered to the lyso-
somes, as suggested from the observation that the degradation 
of the lipoproteins was inhibited upon incubation with chloro-
quine (a lysosomal inhibitor). The ACAT activity is dependent 
on the delivery of cholesterol via saturable, ·high-affinity 
bound material, and was induced by both LDL and AcLDL binding 
to the cell surface. Although the delivery of cholesterol 
from AcLDL caused an induction in the ACAT activity and a 
down-regulation of the LDL receptor, neither this cholesterol 
nor that from LDL regulated the AcLDL receptor. 
At this stage it is possible to postulate on the ro1e of 
endothelial cells in the formation of the atherosclerotic 
plaques. It has been shown that endothelial cells, whether 
sparse or confluent, do not accumulate excessively large a 
amounts of cholesterol upon exposure to AcLDL. Thus, it 
was of interest that smooth muscle cells. which were incubated 
with medium that had been previously incubated with endothelial 
cells in the presence of AcLDL, accumulated a large amount of 
cholesteryl esters (85). It is attractive to postulate that 
in the process of diacytosis, the AcLDL becomes modified in 
such a way as to be recognized by smooth muscle cells. 
Although in cultured cells there is the possibility of retro-
endocytosis (165) of the AcLDL particle back into the medium, 
whether the.:!!!_ vivo situation would retro-endocytose AcLDL 
back into the bloodstream or into the interstitial fluid, is 
still unknown. In comparing endothelial cells to macrophages. 
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the latter appear to possibly have a dual role in the forma-
tion of an atherosclerotic plaque, i.e. to alter negatively-
modified LDL for uptake by smooth muscle cells (85,86), as 
well as to accumulate cholesteryl esters upon exposure to 
the negatively-modified LDL (76,77,78,127, 133,161). In 
contrast, endothelial cells do not appear to accumulate 
cholesteryl esters markedly under any conditions, but may 
be involved in the modification of lipoproteins, thus result-
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